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Magnetic resonance imaging (MRI) is a noninvasive technique that allows imaging 
three dimensional volume through the body, providing superior soft tissue contrast 
compared to CT without ionizing radiation. MRI can be used to detect field inhomogeneity 
induced by blood iron molecules such as deoxyhemoglobin, methemoglobin, and 
hemosiderin, providing opportunities to identify and quantify these molecules and oxygen 
consumption, especially in brain. This dissertation reports: 1) a clinical study on 
intracranial hematoma evolution using quantitative susceptibility mapping (QSM); 2) a 
new magnetic susceptibility based signal model and technique to quantitatively map 
cerebral metabolic rate of oxygen (CMRO2) and oxygen extraction fraction (OEF) using 
QSM; 3) a new algorithm to improve SNR of QSM-based CMRO2 using prior knowledge; 
4) a new algorithm called minimal local variance (MLV) to improve clinical practicality 
of QSM-based CMRO2 by removing the requirement of blood flow challenge. The 
potential impacts, limitations and future directions of each studies are also discussed. 
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Chapter 1 
 
 
 
 
Introduction 
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1.1 SUMMARY OF CONTRIBUTIONS 
Magnetic resonance imaging (MRI) is a noninvasive technique that allows imaging 
three dimensional volume through the body. Unlike computed tomography (CT) and x-ray 
imaging, MRI provides superior soft tissue contrast without ionizing radiation by using 
physical principles similar to that of nuclear magnetic resonance (NMR) spectroscopy with 
the addition of magnetic field gradients. MRI physics will be discussed in greater details 
in chapter 2.  
In this thesis, quantitative susceptibility mapping (QSM) has been used to study 
intracerebral hemorrhage (ICH) and brain oxygenation. Briefly, QSM generates a three-
dimensional map by solving magnetic field to susceptibility source inverse problem, where 
voxel intensity is linearly proportional to tissue magnetic susceptibility. QSM physical 
principle will be discussed in greater details in the chapter 2. 
Chapter 2 also presents the underlining principles of arterial spin labeling (ASL), 
another MRI imaging technique used in conjunction with QSM to study brain oxygenation 
in this thesis. The definition and physiological meanings of cerebral metabolic rate of 
oxygen (CMRO2) and oxygen extraction fraction (OEF) are also discussed. 
Chapter 3 presents a clinical study which investigate the magnetic susceptibility of 
hematomas at various stages using QSM. ICH is a life threatening medical condition, which 
require accurate staging and monitoring of the developments of hematomas. The blood 
degradation process in ICH has been characterized qualitatively but not quantitatively on 
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MRI using standard T1 weighted (T1w), T2 weighted (T2w), and T2* weighted gradient 
echo (T2*w) imaging (1-3). The study demonstrates the potential of QSM to provide more 
accurate hematoma staging and to quantify blood degradation products.  
Stroke is yet another life threatening medical conditions, which require prompt and 
accurate diagnosis and treatments. The quantitative mapping of cerebral metabolic rate of 
oxygen (CMRO2) and oxygen extraction fraction (OEF) has long been sought after in both 
research and clinical settings as important indicators for neural viability and activity in 
stroke (4-6). As oxygen is released to brain tissue, the weakly diamagnetic oxyhemoglobin 
(oHb) turns into to the strongly paramagnetic deoxyhemoglobin (dHb) and induces 
magnetic field inhomogeneity detectable by MRI (7,8). Several MRI techniques have been 
proposed to map dH: 1) Quantitative imaging of extraction of oxygen and tissue 
consumption (QUIXOTIC), which uses a velocity-selective spin labeling to selectively 
map venous blood T2 and oxygenation (9). 2) Calibrated fMRI, which models the 
magnitude R2* decay of the blood oxygen level dependent (BOLD) signal as a complex 
function of dH concentration ([dH]), typically estimating [dH] from signal measurements 
at two vascular challenges such as hyperoxia and hypercapnia to obtain CMRO2 (10-12). 
3) quantitative BOLD, which uses a specific venous geometry of randomly oriented tubes 
to model [dH] dependence of signal generated in asymmetric spin echo (13,14) or 3D 
multi-echo gradient echo data (15). Some of the limitation of these approaches includes: 1) 
sensitive to scanning parameters; 2) limited clinical practicality with multiple blood flow 
challenges. 
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In chapter 4, a new signal model based on magnetic susceptibility of blood and non-
blood tissue is proposed to overcome some of the limitations mentioned above. An imaging 
technique and an algorithm based on the new signal model were invented to quantitatively 
map CMRO2 and OEF on 13 healthy subjects (n=13, 13 males, mean age 35 ± 9.5 years) 
using 3T MRI scanners (HDxt, GE Healthcare, Waukesha, WI, USA), and an 8-channel 
receive head coil. The study demonstrates that QSM can be used in conjunction with 
cerebral perfusion measurements before and after a vasoconstricting caffeine challenge to 
map CMRO2 and OEF. 
In chapter 5, a new algorithm is proposed to denoise QSM based CMRO2 and OEF 
maps by incorporating prior knowledge (Bayesian approach) during image reconstruction. 
The prior knowledge include a right-handed preconditioner, a CMRO2 global constraint 
derived from straight sinus, and a physiological lower and upper bounds of 0 to 100 % on 
OEF maps. Caffeine administration is also replaced by hyperventilation as the vaso-
restrictive challenge in order to reduce the protocol time. The study shows hyperventilation 
is a feasible, reproducible and efficient vasoconstrictive challenge for QSM based 
quantitative CMRO2 mapping in healthy subjects with good reproducibility and offers 4-
fold protocol time reduction compared to using caffeine as a challenge. Constrained 
optimization within physical range of OEF provides substantial reduction of noise errors 
in CMRO2 and OEF maps. The applicability of this protocol for a general patient 
population remains to be investigated. 
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In chapter 6, a new algorithm named minimal local variance (MLV) is proposed to 
remove the requirement of vaso challenges in the QSM-based CMRO2 technique to further 
improve its clinical practicality. The lack of susceptibility and perfusion measurements of 
the challenged brain state leads to ill-posedness of the optimization problem, more 
specifically two unknowns with one equation per voxel. MLV overcomes the ill-posedness 
by assuming constant CMRO2 and non-blood tissue susceptibility within each tissue type 
(gray and white matter) across small regions of the brain. This assumption groups multiple 
equations to invert two unknowns within each tissue type and small regions. The study 
demonstrated the feasibility of a noninvasive CMRO2 mapping without vascular challenge 
based on QSM and CBF using MLV. In vivo imaging in heathy subjects demonstrates that 
the CMRO2 and OEF maps obtained with the proposed MLV method agree well with those 
obtained using a blood flow challenge based method. 
Chapter 7 presents the future work for ICH study using QSM and QSM based 
CMRO2 technique.   
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2.1 MRI PHYSICS 
2.1.1 Signal Generation 
A nucleus with an uneven atomic number possesses an intrinsic angular momentum. 
Combined with its net positive charge a net magnetic moment is formed. In MRI, such 
nucleus is referred to as a spin. This spin precession phenomenon can be described by Eq 
[2.1]. 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= 𝛾𝛾𝛾𝛾 × 𝐵𝐵0                                                   [2.1] 
Here B0 is an external magnetic field. μ is the magnetic moment precesses along B0 
direction (z). 𝛾𝛾 = 42.58𝑀𝑀𝑀𝑀𝑀𝑀/𝑇𝑇 is gyromagnetic ratio for proton.   
Under normal conditions, there is no net magnetic moment in a bulk sample since 
the spins are randomly orientated. When the sample such as water is placed in an external 
magnetic field B0, the spins of 1H nucleus tend to align with B0 in a parallel or an anti-
parallel fashion. Since the parallel state has lower energy, a larger number of spins adopt 
this state and create a net magnetic moment.  
To generate MRI signal, a process called RF excitation is used. In this process, a 
radio frequency field (RF) B1, often at gyromagnetic frequency for efficiency, is applied 
for a short period time to tip the spin away from B0 direction for a certain degree (flip 
angle), forming a magnetization component in the transverse plane (x,y). After RF 
excitation, spins try to re-align with B0 due to energy exchange of spins and their 
surroundings. The longitudinal bulk magnetization Mz recovers to M0 in time T1, or spin-
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lattice relaxation time. Transverse magnetization Mxy decays in time T2, or spin-spin 
relaxation time. The bulk magnetization after RF excitation can be described using Bloch 
equation [2.2]: 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= (𝛾𝛾𝑀𝑀 × 𝐵𝐵) − �𝑑𝑑𝑧𝑧−𝑑𝑑𝑧𝑧0�?̂?𝑧
𝑇𝑇1
−
𝑑𝑑𝑥𝑥𝑥𝑥�+𝑑𝑑𝑦𝑦𝑦𝑦�
𝑇𝑇2
                                  [2.2] 
Signals generated by this transverse magnetization can be detected by MRI. The different 
T1 and T2 of various tissue types generate contrasts on T1w and T2w images.  
 
2.1.2 Signal Encoding 
To spatially encode spins, a magnetic field gradient G is used. At each location x, 
the spin experiences a slightly different magnetic field, B0 and ∆B(x). The precession 
frequency ω can be written as   
𝜔𝜔(𝑥𝑥) = 𝛾𝛾�𝐵𝐵0 + ∆𝐵𝐵(𝑥𝑥)�.                                         [2.3] 
The gradient used in MRI is often linear in space and its magnitude varies in time t. Hence, 
𝑥𝑥𝑥𝑥(𝑡𝑡) =  ∆𝐵𝐵(𝑥𝑥, 𝑡𝑡),                                             [2.4] 
Here G(t) is the vector of gradient in T/m at time t. The signal S(t) can then be expressed 
as  
𝑆𝑆(𝑡𝑡) = ∫ 𝐶𝐶(𝑥𝑥)𝜌𝜌(𝑥𝑥)𝑒𝑒−𝑖𝑖𝑖𝑖 ∫ 𝐺𝐺(𝜏𝜏)𝑑𝑑𝜏𝜏𝑥𝑥𝑡𝑡0 𝑑𝑑𝑥𝑥.∞−∞                                [2.5] 
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Here x is the spatial coordinate. C(x) is the sensitivity of the coil. ρ(x) is proton density 
including the relaxation effect. Equation 2.5 can be rewritten in k-space coordinate with 
𝑘𝑘(𝑡𝑡) = 𝛾𝛾 ∫ 𝑥𝑥(𝜏𝜏)𝑑𝑑𝜏𝜏𝑑𝑑0                                              [2.6] 
Substituting Eq. 2.6 into Eq. 2.5, we have 
 𝑆𝑆(𝑘𝑘) = ∫ 𝐶𝐶(𝑥𝑥)𝜌𝜌(𝑥𝑥)𝑒𝑒−𝑖𝑖𝑖𝑖𝑥𝑥𝑑𝑑𝑥𝑥.∞−∞                                     [2.7] 
From Eq. 2.7, the signal acquired by MRI S(k) is the spatial Fourier transform of the object 
being imaged. 
  
2.1.3 Signal Acquisition 
During imaging, Mxy varies over time which generates magnetic flux and electric 
current in receiver coils. Two of the most common acquisition sequences are spin echo and 
gradient echo. In the case of spin echo, a 90o RF pulse followed by another 180o refocusing 
RF pulse are used. The 90o pulse transfer z magnetization (Mz) completely to transverse 
plane (Mxy). The refocusing RF reverse effects induced by field inhomogeneities. With 
sufficient magnetization recovery time this combination allows the largest possible signal 
and the minimal field inhomogeneities effects, which is ideal for imaging quality. Spin 
echo sequence can produce T1w, T2w and proton density (PD) weighted images depending 
on time of echo (TE) and time of repetition (TR). However, in general spin echo sequences 
require longer acquisition time. 
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Unlike spin echo, gradient echo uses a single excitation pulse with a flip angle α 
followed by a gradient pulse to create the echo. This pulse sequence can also produce T1w, 
T2w, and PD-weighted images with much shorter acquisition time due to its shorter TRs. 
However, they are affected by magnetic field inhomogeneity and imaging parameters such 
as flip angle, TE and TR. This shortens the apparent spin-spin relaxation time. The 
combined decay rate, T2 and field inhomogeneity, is known as T2*. 
1
𝑇𝑇2∗
= 1
𝑇𝑇2
+ 1
𝑇𝑇2′
 𝑜𝑜𝑜𝑜 𝑅𝑅2∗ = 𝑅𝑅2 + 𝑅𝑅2′                                [2.8]  
After data acquisition any residual transverse magnetization can form a Hahn or 
partial echo, which can be refocused by subsequent RF pulses and corrupt the images. One 
way to counter this issue is to apply a large gradient between data acquisition and the next 
RF pulse to completely dephase or to spoil the residual transverse magnetization. This type 
of sequence is called spoiled gradient echo (SPGR), which is the primary type used in this 
dissertation for GRE magnitude images, R2* maps, and quantitative susceptibility maps 
(QSM).   
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 Figure 2.1. Pulse diagram of SPGR. A large gradient is played out between data acquisition 
and the next RF pulse to completely dephase or to spoil the residual transverse 
magnetization. 
 
2.1.4 Sampling Trajectory 
There are several k-space sampling strategies. Cartesian sampling is one of the most 
common strategies where k-space is sampled line by line. This is achieved by playing out 
gradients along x, y and z axis to offset to appropriate k-space coordinate after applying a 
RF and a slice selection gradient. Then a readout gradient is applied on the x-axis, moving 
the trajectory in the x-axis direction and sampling one k-space line. After readout y and z 
axis gradients are rewound. A spoiler gradient is played on x-axis to spoil any residual 
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magnetization to prevent Hahn echo. This is the primary sampling strategy for SPGR 
sequence in this dissertation.      
 
2.1.5 Image Reconstruction 
The signal acquired by MRI is the spatial Fourier transform of the object being 
imaged. However, in real world it is impossible to sample the continuum of k-space. If the 
data is sampled on a Cartesian grid that satisfies Nyquist theorem, an inverse discrete 
Fourier transform (DFT) can be performed to reconstruct images. 
𝜌𝜌�(𝑥𝑥, 𝑦𝑦, 𝑀𝑀) = 1
�𝑁𝑁𝑥𝑥𝑁𝑁𝑦𝑦𝑁𝑁𝑧𝑧
∑ ∑ ∑ 𝑆𝑆(𝑙𝑙,𝑚𝑚,𝑛𝑛)𝑒𝑒𝑖𝑖2𝜋𝜋𝑥𝑥𝜋𝜋 𝑁𝑁𝑥𝑥� 𝑒𝑒𝑖𝑖2𝜋𝜋𝑦𝑦𝜋𝜋 𝑁𝑁𝑦𝑦� 𝑒𝑒𝑖𝑖2𝜋𝜋𝑧𝑧𝜋𝜋 𝑁𝑁𝑧𝑧�𝑁𝑁𝑧𝑧−1𝜋𝜋=0𝑁𝑁𝑦𝑦−1𝜋𝜋=0𝑁𝑁𝑥𝑥−1𝜋𝜋=0       
[2.8] 
where 𝜌𝜌�(𝑥𝑥,𝑦𝑦, 𝑀𝑀) is the magnetization distribution of the imaging object in real space. x, y, 
z is the coordinates in real space. l, m, n is the coordinates in k-space. Nx, Ny and Nz are 
the number of k-space sampling points in three axis. In practice, inverse fast Fourier 
transform (FFT) is used to reduce the reconstruction time.      
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 Figure 2.2. Images are obtained after performing DFT on K-space data.   
 
2.1.6 Parallel Imaging 
In modern MRI scanners, most receiver coils consist of array of coil elements. Each 
coil element has its own coverage and sensitivity. This design allows accelerated data 
acquisition through parallel imaging. There are two main categories: k-space based and 
image-space based. A typical k-space based method is called GeneRalized Autocalibrating 
Partially Parallel Acquisitions (GRAPPA) which takes advantage of the smoothness of coil 
sensitivity and reformats k-space points as a weighted average of the surrounding points 
and/or the points from other coils.  
In this thesis, an image-space based accelerating technique called Array Spatial 
Sensitivity Encoding Technique (ASSET, GE health care) is used (1). ASSET is based on 
the SENSitivity Encoding (SENSE) method (2). Assuming the accelerating factor is R, 
each voxel in the aliased coil image is the sum of R voxels in the fully sampled coil image 
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weighted by the coil sensitivity. With measurements from multiple coils, a linear system 
can be constructed. 
�
𝜌𝜌1�
𝜌𝜌2�
⋮
𝜌𝜌𝑁𝑁𝑁𝑁�
� = � 𝐶𝐶1,1𝐶𝐶2,1 𝐶𝐶1,2𝐶𝐶2,2 … 𝐶𝐶1,𝑅𝑅⋯ 𝐶𝐶2,𝑅𝑅
⋮ ⋮ ⋱ ⋮
𝐶𝐶𝑁𝑁𝑁𝑁,1 𝐶𝐶𝑁𝑁𝑁𝑁,2 ⋯ 𝐶𝐶𝑁𝑁𝑁𝑁,𝑅𝑅
� �
𝜌𝜌1
𝜌𝜌2
⋮
𝜌𝜌𝑅𝑅
�                              [2.9] 
Here 𝐶𝐶𝜋𝜋,𝜋𝜋 is the sensitivity of coil m at location n. Nc is the number of coil elements. 𝜌𝜌� is 
a voxel of aliased coil images from different coils. ρ are the voxels from different locations 
of the fully sampled image. When the linear system is over determined, or Nc > R, fully 
sampled images can be calculated by solving Eq. 2.9.  
 
2.2 QUANTITATIVE SUSCEPTIBILITY MAPPING 
Magnetic susceptibility is a physical quantity that measure the degree of 
magnetization of a material in response to an applied magnetic field. Many biomolecules 
such as hemoglobin and bone contain iron and calcium ions and have different magnetic 
susceptibility. QSM quantitatively maps tissue magnetic susceptibilities, opening a new 
venue to quantify these biomolecules. 
The unit for volume susceptibility is ml/ml, or unitless. The unit for molar 
susceptibility is m3/mol (SI), or cm3/mol (CGS). The conversion of volume susceptibility 
between SI and CGS is 
𝑥𝑥𝑣𝑣
𝑆𝑆𝑆𝑆 = 4𝜋𝜋𝑥𝑥𝑣𝑣𝐶𝐶𝐺𝐺𝑆𝑆                                                  [2.10] 
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In this dissertation, SI units are used unless otherwise notice. All magnetic 
susceptibility is relative to water / cerebrospinal fluid (CSF) unless otherwise notice. 
 
2.2.1 Foundations of QSM 
The longitudinal magnetic field induced by the imaging object can be expressed as 
(3) 
𝛿𝛿𝑏𝑏(𝑜𝑜) = 𝑑𝑑(𝑜𝑜) ⊗𝑥𝑥(𝑜𝑜)                                            [2.11] 
Where r is the spatial coordinate. 𝛿𝛿𝑏𝑏(𝑜𝑜) is the magnetic field induced by the imaging object 
scaled by B0, also known as the local field. This is obtained after removing background 
field generated by large susceptibility sources such as air, bone, and fat outside the volume 
of interest from the total field. In this dissertation, projection onto dipole fields (PDF) is 
the primary algorithm for background field removal (4).  𝑥𝑥(𝑜𝑜) is the spatial susceptibility 
distribution of the imaging object. ⊗ is the convolution operator.  𝑑𝑑(𝑜𝑜) is the dipole kernel. 
 𝑑𝑑(𝑜𝑜) = 3𝑁𝑁𝑐𝑐𝑐𝑐2𝜃𝜃−1
4𝜋𝜋𝑟𝑟3
                                                [2.12] 
Θ is the angle between 𝑜𝑜 − 𝑜𝑜′ and B0. Eq. 2.11 can be expanded as (5) 
𝛿𝛿𝑏𝑏(𝑜𝑜) = ∫ 𝑥𝑥(𝑜𝑜′) 3𝑁𝑁𝑐𝑐𝑐𝑐2�𝜃𝜃𝑟𝑟−𝑟𝑟′�−14𝜋𝜋|𝑟𝑟′−𝑟𝑟|3𝑟𝑟′≠𝑟𝑟 𝑑𝑑3𝑜𝑜′                         [2.13] 
𝑥𝑥(𝑜𝑜) can be computed by de-convolution of the dipole kernel 𝑑𝑑(𝑜𝑜). For efficiency the 
convolution is executed as a multiplication in k-space. However, the dipole kernel is zero 
23 
 
at the cone surface 3𝑐𝑐𝑜𝑜𝑐𝑐2𝜃𝜃 = 1,𝜃𝜃 = ±54.7𝑐𝑐in both image and k spaces. This leads to ill-
posedness in the inversion. There are several approaches to encounter the ill-posedness (6): 
1) Calculation Of Susceptibility through Multiple Orientation Sampling (COSMOS) where 
the ill-posedness is solved by oversampling from multiple orientations; 2) Thresholded k-
space division (TKD) where underdetermined k-space data of the dipole kernel are set to a 
predetermined non-zero value; 2) Morphological-enabled dipole inversion (MEDI) where 
structural prior generated from GRE magnitude images are incorporated in the de-
convolution. In this dissertation, MEDI is the primary algorithm for QSM reconstruction. 
 
Figure 2.3. Zero cone surface at 𝜃𝜃 = ±54.7𝑐𝑐 of dipole kernel in K space. 
 
2.2.2 Morphology-Enabled Dipole Inversion (MEDI)    
From COSMOS results we observed that the structural edges in the susceptibility 
maps closely match the edges of GRE magnitude images generated from the same data. 
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MEDI takes advantage of this observation and employs a weighted L1 minimization to 
penalize susceptibility voxels that are not parts of edges on GRE magnitude images. The 
cost function is (7): 
𝑥𝑥 = argmin
𝑥𝑥
‖𝑀𝑀∇𝑥𝑥‖1 + 𝜆𝜆‖𝑊𝑊(𝛿𝛿 − 𝐹𝐹𝐷𝐷𝑥𝑥)‖22                            [2.14] 
Here ∇ is a 3D gradient operator that generate edge maps on susceptibility map 𝑥𝑥 in x,y, 
and z directions. 𝑀𝑀 is a binary edge maps generated from GRE magnitude images where 
the voxel value is zero when its gradient is significant (5 times larger than noise), and is 
one otherwise. Λ is reconstruction parameter. W is a weighting matrix based on SNR. FD 
is  
𝐹𝐹𝐷𝐷 = 𝐹𝐹−1𝐷𝐷𝐹𝐹                                                 [2.15] 
Where D is the dipole kernel expressed in the Fourier domain.  
 Susceptibility map 𝑥𝑥 is obtained by solving Eq. 2.15 using a conjugated gradient 
method with λ determined by L-curve. Typical λ for a 3T MRI scanner is ranged from 500 
to 1500.  
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2.3 ARTERIAL SPIN LABELING (ASL) AND CEREBRAL BLOOD FLOW 
MAPPING 
Blood flow is critical in oxygen and nutrients delivery to tissues, especially in brain. 
Usually quantified in the unit of ml per 100g of tissue per min, cerebral blood flow (CBF) 
can be measured using a tracer in blood (8). This tracer can 1) emit radioactive signal and 
detected by positron emission tomography (PET); 2) increase signal attenuation and 
detected by computed tomography; 3) increase magnetization and detected by MRI.  
  Arterial spin labeling is a non-invasive MRI technique for quantitatively mapping 
CBF without contrast agent, which is the primary technique used in this dissertation.  
 
2.3.1 Foundations of ASL 
During ASL scanning, a pair of control and tagged images were acquired. In the 
tagged images, water protons in arterial blood downstream, usually in the neck region, are 
magnetically labelled using 180 degree RF inversion pulses. After some delay time, the 
labelled blood reached capillaries where it exchanges with tissue water and reduces total 
tissue magnetization. By subtracting tag from control images any static tissue signal is 
removed. The remaining signal is proportional to CBF.  
There are several ASL variants (8): 1) continuous ASL (CASL) utilizes a continuous 
RF pulse (2~4 sec) in combination with a slice-selective gradient to tag arterial blood in a 
narrow plane just below imaging plane. This in theory allows high SNR. However, CASL 
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has several drawbacks such as magnetization transfer effects, high specific absorption rate 
(SAR), and requirement of additional hardware. 2) pulse ASL (PASL) utilizes short RF 
pulses to tag a blood volume (tag region). PASL has advantages of ease of implementations 
and reduced MT effects. However, it is sensitive to transit delay, time needed for tag blood 
to flow from tag region to imaging plane. The SNR also suffered compared to CASL. 3) 
pseudo-Continuous ASL (pCASL) is hybrid between CASL and PASL. This technique 
utilizes a chain of discrete RF pulses in combination with a gradient wave to mimic CASL’s 
continuous RF pulses for tagging. This technique has advantages of reduce MT effects, no 
need for additional hardware, and relative high SNR. The main disadvantages are 
susceptible to field inhomogeneity, eddy currents and post label delay time. In this 
dissertation, 3DASL, variation of pCASL from GE healthcare is the primary technique for 
CBF maps. 
 
Figure 2.4. PCASL tagging plane and imaging volume.  
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2.3.2 pCASL Post Processing  
CBF images were calculated using a single-compartment model after subtraction of 
labeled from control images (9,10). 
𝐶𝐶𝐵𝐵𝐹𝐹 = 𝜆𝜆(1 − 𝑒𝑒−𝑇𝑇𝑆𝑆𝑆𝑆𝑆𝑆 𝑇𝑇1𝐺𝐺𝐺𝐺⁄ ) × 𝑒𝑒𝑤𝑤 𝑆𝑆1𝐵𝐵⁄
2𝑇𝑇1𝐵𝐵(1−𝑒𝑒−𝜏𝜏 𝑆𝑆1𝐵𝐵⁄ )𝜀𝜀𝑁𝑁𝜀𝜀𝜀𝜀 ∆𝑆𝑆𝑆𝑆0                   [2.16] 
Here λ = 0.9 is partition coefficient. TSAT  = 2 sec is saturation recovery time for proton 
density weighted (PDw) images. T1GM = 1.2 sec is the correction for saturation recovery 
on PDw images. w = 1.5 sec is the post label delay. T1B = 1.6 sec is T1 of blood at 3.0 T. 
τ = 1.5 sec is labeling time. ε = 0.6 is labeling efficiency. NEX is the number of excitation 
for perfusion weighted images, or raw difference images.  ∆S is the raw difference images. 
S0 is the PDw images.  
 This a single-compartment model and equation have been commercialized in GE 
FuncTool post processing software and it is used for CBF maps computation in this 
dissertation.  
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Chapter 3 
 
 
 
 
Investigation of Blood Degradation in Hemorrhagic Patients Using 
QSM 
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3.1    ABSTRACT 
Purpose: 
To investigate the magnetic susceptibility of intracerebral hemorrhages (ICH) at 
various stages by applying quantitative susceptibility mapping (QSM).  
Materials and Methods: 
Blood susceptibility was measured serially using QSM after venous blood 
withdrawal from healthy subjects. Forty-two patients who provided written consent were 
recruited in this institutional review board approved study. Gradient echo MRI data of the 
42 patients (17 females; 64±12 yrs) with ICH were processed with QSM. The 
susceptibilities of various blood products within hematomas were measured on QSM. 
Results: 
Blood susceptibility continually increased and reached a plateau 96 hours after 
venous blood withdrawal. Hematomas at all stages were consistently hyperintense on QSM. 
Susceptibility was 0.57 ± 0.48, 1.30 ± 0.33, 1.14 ± 0.46, 0.40 ± 0.13, and 0.71 ± 0.31 parts 
per million (ppm) for hyperacute, acute, early subacute, late subacute and chronic stages 
of hematomas respectively. The susceptibility decrease from early subacute (1.14ppm) to 
late subacute (0.4ppm) was significant (p<0.01). 
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Conclusion: 
QSM reveals positive susceptibility in hyperacute hematomas, indicating that even 
at their hyperacute stage, deoxyhemoglobin may exist throughout the hematoma volume, 
not just at its rim as seen on conventional T2* imaging. QSM also reveals reduction of 
susceptibility from early subacute to late subacute ICH, suggesting that methemoglobin 
concentration decreases at the late subacute stage. 
Keywords: Magnetic Susceptibility, QSM, Intracerebral Hemorrhage, CT 
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3.2    INTRODUCTION: MRI IN HEMORRHAGIC PATIENTS 
The blood degradation process in intracerebral hemorrhage (ICH) has been 
characterized qualitatively but not quantitatively on MRI using standard T1 weighted 
(T1w), T2 weighted (T2w), and T2* weighted gradient echo (T2*w) imaging (1-3). It is 
generally assumed that blood degradation products in intracerebral hematomas are 
composed primarily of oxyhemoglobin (oxyHb) in the hyperacute stage (<24h), 
deoxyhemoglobin (deoxyHb) in the acute stage (1~3 days), intracellular methemoglobin 
(metHb) in the early subacute stage (3~7 days), extracellular metHb in the late subacute 
stage (7~14 days), and hemosiderin in the chronic stage (>14 days). During blood 
degradation, the molar magnetic susceptibility monotonically increases, from slightly 
negative relative to CSF in oxyHb to highly positive in deoxyHb, metHb, and hemosiderin.  
Quantitative Susceptibility Mapping (QSM) has recently been applied to quantify 
cerebral microbleed burden (4), hematoma volume (5), blood leakage in cerebral cavernous 
malformation (6,7) , and to differentiate hemorrhages from calcifications (8,9). Because 
QSM directly quantifies the magnetic susceptibility of tissue, it provides an opportunity to 
quantitatively characterize hematomas by using MRI, especially at the hyperacute/acute 
phase where treatment is critically needed. Here, we apply QSM to investigate the magnetic 
susceptibility of hematomas at various stages.  
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3.3    EXPERIMENTS AND ANALYSIS 
The susceptibility of hematomas was investigated using QSM of blood drawn from 
healthy subjects and using QSM performed in ICH patients at various stages. All magnetic 
susceptibility reported in this study were measured in SI units relative the cerebral spinal 
fluid (CSF) in subjects and relative to water in phantoms. 
 
3.3.1    Blood Experiment 
The blood experiment was approved by our institutional review board to study the 
change in blood susceptibility over time following venous blood withdrawal from healthy 
subjects. A phantom was constructed with 5mL transfer pipets (Thermo Scientific, 
Waltham, MA) embedded in a plastic container with 1% agar solution to support the blood 
tube. The same procedure was repeated on five healthy volunteers. For each subject, 5 ml 
venous blood was drawn and immediately injected into the tube. The plastic container was 
kept in a 37°C water bath when not being scanned. The first scan started immediately after 
blood withdrawal. The blood phantom was scanned every hour during the first 8 hours, 
then at 16 hours, 24 hours, and every day thereafter up to 7 days.  
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3.3.2    Patient Experiment 
This study was approved by our institutional review board and written consent was 
obtained from patients or their families. From September 2010 to December 2012, patients 
suspected of hemorrhagic strokes were prescribed either MRI or CT and were recruited for 
this study. After their conditions stabilized, a follow-up CT or MRI scan that was 
complementary to the initial scan was performed. If the initial scan was an MRI scan and 
the hematoma was chronic, the follow-up CT scan was sometimes omitted. 42 patients (25 
males and 17 females; 41~89 years old, mean ± standard deviation, 64±12) with 
hematomas at various stages were scanned consecutively during this time period and 
included in this study. The interval between CT and MR imaging ranged from less than an 
hour to 8 days, but only seven of them were longer than 25 hours, resulting in a mean 
interval of 37 hours and a median of 2 hours. At the time of the initial scan, the symptom 
duration was less than 24 hours for 4 patients, 1~3 days for 10 patients, 3~7 days for 5 
patients, 7~14 days for 11 patients, and more than 14 days for 12 patients. After screening 
the images, one patient in the >14 days category was excluded due to corrupted image 
quality in QSM.  
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3.3.3    Imaging Protocol and Data Reconstruction 
3.3.3.1    Blood Experiment 
3D multi-echo spoiled gradient echo (SPGR) were acquired on a 3.0 Tesla MR 
system (Signa HDx, GE, United States) using an 8-channel brain coil. The imaging 
parameters were: flip angle = 25o, first TE=2.1 ms, echo spacing=2.8 ms, 11 echos, 
TR=33.4 ms, voxel size=1x1x1 mm3, scan time = 4 mins; QSM images were calculated 
from gradient echo complex images using the morphology enabled dipole inversion 
method (3,10,11). 
 
3.3.3.2    Patient Experiment 
MRI was performed on a 3.0 Tesla MR system (Magnetom Verio, Siemens, 
Erlangen, Germany) using a 12-channel head coil with the following pulse sequences: (a) 
T1-weighted (T1w) spin echo (TR = 431ms, TE = 13ms) (b) T2-weighted fluid-attenuated 
inversion recovery (T2w-FLAIR, TR = 6.4s, TE = 110ms, TI = 2s) or T2-weighted images 
(T2w, TR = 9s, TE =100ms), and (c) 3D T2*-weighted spoiled multiecho gradient echo 
(T2*w). Imaging parameters for the multi-echo GRE sequence were as follows: flip angle, 
15°; repetition time, 58 msec; number of echoes, 8; first echo time, 5.7 msec; echo time 
spacing, 6.7 msec; pixel bandwidth, 500Hz; field of view, 24 cm; matrix, 384 × 288; 
section thickness, 2 mm; parallel imaging acceleration factor, 2; and total acquisition time, 
about 6 minutes. T2*w magnitude images were reconstructed by taking the square root of 
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sum of squares of all the echoes. The QSM was reconstructed from the multiecho GRE 
data using the morphology enabled dipole inversion method (10-12).  
CT was performed using a 64-detector CT scanner (Lightspeed VCT; GE 
Healthcare, Milwaukee, WI) with the following parameters: 260 mAs, 120 kV, 5mm slice 
thickness, 1.375:1 pitch, and 512 × 512 matrix.  
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3.3.4    Image Analysis 
3.3.4.1    Blood Experiment 
Regions of interest (ROIs) covering the entire clot were manually drawn and used 
to measure the mean and standard deviation of susceptibilities at different time points. 
 
3.3.4.2    Patient Experiment 
Two neuroradiologists with at least 10 year-experience classified the ages of the 
hematomas as hyperacute, acute, early subacute, late subacute, and chronic stages, and 
corresponding blood products, based on characteristic signal intensity patterns on T1w, 
T2w-FLAIR, T2*w MRI and CT (2,13). A hematoma might have multiple ROIs (Fig. 3.1). 
Susceptibility values were measured from QSM on ROIs of the same blood product. 
Cerebrospinal fluid (CSF) susceptibility values in the lateral ventricles without evidence 
of hemorrhages were used as the susceptibility reference. For each type of blood product, 
the mean and standard deviation of the blood products’ susceptibility values were recorded.  
 
3.3.5    Statistical Analysis 
QSM ROI measurements were grouped based on their hematomas stages and the 
corresponding blood products in statistical analysis.  One-way analysis of variance 
(ANOVA) was performed to assess if the susceptibility differences among the five stages 
were significant. One-sample t-tests with a significance level of 5% were performed to 
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assess if measured susceptibility values in each stage were significantly above zero 
(relative to CSF). Two-sample unpaired t-tests with intracluster correlation adjustments for 
multiple ROIs within the same patient (14) and a significance level of 5% were performed 
to assess if the susceptibility changes between two consecutive stages were statistically 
significant: hyperacute vs acute, acute vs early subacute, early subacute vs late subacute, 
and late subacute vs chronic. 
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3.4    RESULTS 
3.4.1    Blood Experiment 
Blood coagulated about 9 min after drawing. Hematoma retraction started 
immediately after coagulation and stabilized within 1-2 hours. Figure 3.3 shows the time 
course of blood clot susceptibilities (n = 5). Susceptibility monotonically increased from 
456±91 ppb (parts per billion) at the start to a plateau of 1509±60 ppb beginning at 96 
hours.  
 
3.4.2    Patients Experiment 
There were 47 hematomas identified in this study: 4 hyperacute, 5 acute, 15 early 
subacute, 16 late subacute, and 7 chronic. Susceptibility measurements on a total of 78 
ROIs were: 0.57 ± 0.48 parts per million (ppm) from 11 ROIs denoting oxyHb mixed with 
deoxyHb from 11 patients, 1.30 ± 0.33 ppm from 27 ROIs denoting deoxyHb from 26 
patients, 1.14 ± 0.46 ppm from 13 ROIs denoting intracellular metHb from 13 patients, 
0.40 ± 0.13 ppm from 15 ROIs denoting extracellular metHb from 15 patients, and 0.71 ± 
0.31 ppm from 12 ROIs denoting hemosiderin from 10 patients (Fig. 3.4). All values were 
significantly greater than zero (p<0.01). The susceptibility differences among the five 
stages were significant (p<0.01, ANOVA). Figure 3.5 depicts a typical case of a hyperacute 
hematoma having positive susceptibility throughout its volume on QSM and hypointensity 
at its rim on T2w-FLAIR and T2*w. Figure 3.6 illustrates a typical case of an acute 
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hematoma having a core that is hyperintense on QSM but hypointense on T2w-FLAIR and 
T2*w, and isointense on T1w. Figure 3.7 shows typical early and late subacute hematomas, 
demonstrating a reduction of susceptibility in the late subacute stage. 
The susceptibility value at the hyperacute stage (0.57 ppm) was significantly greater 
than zero (p<0.01), suggesting an oxy-deoxyHb mixture. Compared to hyperacute, a 
significant increase of 0.73ppm (p<0.05, df = 14, 32 patients with 5 patients have ROIs in 
both stages) in hematoma susceptibility was found in the acute stage. A statistically 
insignificant (p=0.12, df = 18, 32 patients with 7 patients have ROIs in both stages) 
decrease in susceptibility of -0.17ppm was found in early subacute (intracellular metHb) 
stage when compared to that in the acute stage (deoxyHb). There was an unexpected 
significant decrease of -0.74 ppm (p<0.01, df = 14, 25 patients with 3 patients have ROIs 
in both stages) in susceptibility from early subacute (intracellular metHB) to late subacute 
stage (extracellular metHb; Figs. 3.4 & 3.7). There was a significant increase of 0.31 ppm 
(p<0.01, df = 14, 23 patients with 2 patients have ROIs in both stages) in susceptibility 
from late subacute (extracellular metHB) to chronic stage (hemosiderin).  
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3.5    DISCUSSION 
Data from this QSM study of intracerebral hematomas of various stages suggest the 
following two findings. 1) The susceptibility of hematomas are consistently positive 
relative to CSF even during the hyperacute stage, challenging the traditional model that 
hyperacute hematomas contain mostly oxygenated arterial blood which has slightly 
negative susceptibility (15,16). 2) The susceptibilities of hematomas decrease substantially 
from the acute to subacute stage, thus furthering the MRI literature (1,13) about the late 
subacute stage with new insight for a quantitative model to explain the hemoglobin 
degradation process. 
 In the phantom experiment, the blood susceptibility experienced its most rapid 
increase (0.070 ± 0.014 ppm/hour) during the first 8 hours. In the patient data, the 
quantitative measurement of susceptibility at the acute stage showed a striking agreement 
with the literature (15) and with our theoretical prediction. Assuming deoxyHb is the 
dominating species in acute hematomas, the measured average susceptibility of 1.30 ppm 
agreed with the expected value of 1.37 ppm calculated using Hct × Δχdo , where the 
hematocrit value is Hct = 0.4 and fully deoxygenated hemoglobin susceptibility is Δχdo =3.43ppm  (15). The observed highly positive susceptibility values in hyperacute 
hematomas also suggest the presence of deoxyHb, potentially metHb in addition to 
oxygenated blood. Previously, deoxyHb was regarded as only appearing at the periphery 
of hyperacute hematoma, indicated by a hypointense rim on T2*w images but without 
histological confirmation (1,4,13,17,18). We saw neither a hyperintense rim nor a 
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hypointense center on QSM images of hyperacute hematomas. QSM utilizes the phase 
information from all voxels surrounding the susceptibility source that act as “field 
observers” and not only those occupied by the source. In numerical simulations, it has been 
shown that MEDI is capable of accurately reconstructing the susceptibility of a source even 
when the magnitude signal is artificially removed (10). It has also been shown that in 
patients with calcifications (9) and microbleeds (4), a reconstruction of the susceptibility 
in those lesions is still possible with the correct sign, which is negative and positive using 
CSF as the reference, respectively. Our finding suggests that the degradation of oxyHb to 
deoxyHb in ICH may be faster than expected and may not strictly follow a periphery-
central path. Indeed, the hypointense rim on T2*w images may be caused by the local field 
inhomogeneity at the interface between the hematoma with highly positive susceptibility 
and brain tissue with slightly negative susceptibility. This rapid appearance of deoxyHb in 
a hyperacute hemorrhage may be explained by the ability of hemoglobin to immediately 
release oxygen into the extravascular space during conditions of low oxygen concentration.     
An immediate clinical application of this finding is to identify rebleeding in ICH, 
which may appear as isointense on T1w and hyperintense on T2w images, a scenario which 
is visually similar to conditions of edema. The positive susceptibility values in fresh blood 
allow clear differentiation between rebleeding and edema, which has zero susceptibility. 
The susceptibility decrease from acute to late subacute ICH is unexpected. 
Theoretically, susceptibility should increase from the acute to subacute stage, because iron 
in deoxyHb changed from Fe2+ (four unpaired electrons, 121ppm⋅L/mol) to Fe3+ in metHb 
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(five unpaired electrons, 177ppm⋅L/mol; (19-21). In the blood phantom experiment, we 
observed a monotonically non-decreasing trend. The measured susceptibility reduction 
from acute to late subacute hematomas reflects a lower concentration of metHb. This 
finding may indicate the clearance of metHb by macrophages and the dilution of metHb by 
interstitial fluid in the hematoma due to high water content of the lysed red blood cells and 
inflammation (influx of macrophages) at the late subacute stage (13). Erythrocytes, Hb 
after hemolysis and damaged cell debris are removed quickly by microglia/macrophages 
from the hematoma in immune response to minimize cytotoxic effects (22). As suggested 
by our findings, ICH in the late subacute stage has substantially reduced metHb and 
reduced cellular contents, which are consistent with the observed hyperintensities on both 
T1w and T2w images. The residual metHb is highly mobile and can still cause 
enhancement of 1/T1 and 1/T2, markedly shortening T1 but only marginally shortening T2 
(which is typically much shorter than T1 in contrast enhanced MRI). The hematoma fluid 
dilution of metHb if substantial may be detected by longitudinal monitoring of the 
hematoma volume change during acute and late subacute stages. Assuming that the volume 
is stabilized in the late subacute stage, our finding suggests active metHb clearance.  
The significant increase in susceptibility (0.31ppm) was found in chronic stage ICH 
relative to that in the late subacute stage. This susceptibility increase might be caused by 
the degradation of blood products such as small magnetic domain formation in hemosiderin, 
as well as edema resolution, particularly if the hematoma volume on T2w decreases 
because this would lead to an increase in iron concentration. The removal of metHb by 
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microglia/macrophages seems to have stopped after the late subacute stage, allowing for 
the resolution of the remaining metHb into final stable hemosiderin.  
Despite the lower inner structure contrast of ICH and longer scan time (6 minutes) 
when compared to T1 and T2 weighted images, QSM provided quantitative susceptibility 
measurements of ICH, which have the potential to be converted into concentrations of 
different blood products using molar susceptibilities of blood iron products (dHb, metHb, 
etc.). This feature allows for better understanding of ICH pathophysiology and may be a 
promising monitoring tool in drug trials and in the clinical setting. In addition, since QSM 
images are calculated from magnitude and phase data that was acquired using a gradient 
echo (GRE) sequence (from which both T2* weighted and susceptibility weighted images 
(SWI) can be generated), QSM does not require the addition of a specialized sequence to 
the standard ICH MRI protocol. 
In this study, a major limitation consists of uneven sampling density over various 
stages of ICH, especially for the hyperacute stage, and the lack of longitudinally serial 
imaging. Compared to MR, CT is currently preferred for imaging ICH in the hyperacute 
stage because of shorter scan time and better availability. After CT scans, patients are often 
not stable enough for immediate MRI follow ups within 24hr before hyperacute hematomas 
progress to acute stage. Both of these factors led to small sample size in the hyperacute 
stage. A second limitation of this study is its cross-sectional design. This design was chosen 
because it was relatively difficult to get consent for longitudinal MRI follow up after acute 
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ICH. A third limitation is the lack of histological validation. This issue can be addressed 
through follow up studies of hematoma susceptibility in animal models.  
 
3.6    CONCLUSION 
QSM reveals positive susceptibility relative to CSF in hyperacute hematomas, 
indicating the existence of deoxyhemoglobin even in the hyperacute stage. QSM also 
reveals a significant reduction of susceptibility from acute to late subacute ICH, suggesting 
a decrease in methemoglobin concentration in the late subacute stage. 
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Figure 3.1. Illustration of the quantitative susceptibility measurement of various blood 
products. The hyperintense rim on both T1w (a) and T2w (b) images suggested 
extracellular met-hemoglobin at the periphery of the hematoma. The iso-intense core on 
the T1w image and the corresponding hypointensity on T2w suggested the presence of 
deoxy-hemoglobin in the center. The upper half of the hematoma showed hyperintensity 
in both T1w and T2w images, suggesting extracelluar methemoglobin. The rest of the 
hematoma showed hyperintensity on T1w and hypointensity on T2w images, suggesting 
intracellular methemoglobin. Accordingly, susceptibility values measured in these regions 
are shown as ROIs on QSM (c).  
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 Figure 3.2. QSM of blood phantom over time.  
 
 
Figure 3.3. Susceptibility values of blood clot phantom and corresponding time points, 
demonstrating an increase in susceptibility in the first 4 days, followed by a plateau. 
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 Figure 3.4. Susceptibility values of intracerebral hematomas at various stages and 
corresponding blood products, demonstrating positive susceptibility at the hyperacute stage, 
followed by a significant increase at the acute stage from hyperacute, a significant decrease 
in the late subacute stage from early subacute, and an eventual significant increase at the 
chronic stage. 
 
 
Figure 3.5. Hyperacute ICH in a 61 year old male with MRI obtained 6 hours after 
symptom onset and a follow up CT performed 20 minutes later. a) CT, b)T1w, c)T2w-
FLAIR, d)T2*w and e)QSM. T2w Flair (c) and T2*w (d) reveal a hypointense rim and an 
50 
 
isointense to hypointense core typical for hyperacute ICH. QSM (e) shows a relatively 
isointense rim, especially in the medial part of the lesion, which suggests that the 
hypointense rim seen on T2w Flair and T2*w images may be susceptibility artifacts at the 
core of the hematoma. The core on QSM is hyperintense suggesting a mixture of oxy and 
deoxy Hb. This hyperacute ICH shows a high susceptibility value of 1.32ppm. 
 
 
Figure 3.6. An acute ICH is shown on a)CT, b)T1w, c)T2w-FLAIR, d)T2*w  and e)QSM 
images. CT (a) shows a hyperdense lesion in the right thalamus, T1w (b) shows an 
isointense core, T2w-FLAIR (c) and T2*w (d) both show a hypointense core, and QSM 
shows a hyperintense core.  
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 Figure 3.7. An early subacute ICH is shown on a)CT, b)T1w, c)T2w-FLAIR, d)T2*w and 
e)QSM images, demonstrating a hyperintense periphery with an isointense core on T1w (b) 
but with the appearance of hypointensity on both on T2w-FLAIR (c), T2*w (d) and 
hyperintense on QSM (e). A late subacute ICH is shown on f) CT, g)T1w, h)T2w-FLAIR, 
i)T2*w and j)QSM, demonstrating a hyperintense core on all MRI images (g-j). This late 
subacute ICH has a low susceptibility value of 0.44ppm. 
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Quantitative CMRO2 and OEF Mapping with QSM and ASL 
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4.1    ABSTRACT 
Purpose 
To quantitatively map cerebral metabolic rate of oxygen (CMRO2) and oxygen 
extraction fraction (OEF) in human brains using quantitative susceptibility mapping (QSM) 
and arterial spin labeling measured cerebral blood flow (CBF) before and after caffeine 
vasoconstriction. 
Methods 
Using the multiecho 3D gradient echo sequence and an oral bolus of 200 mg caffeine, 
whole brain CMRO2  and OEF were mapped at 3mm isotropic resolution on 13 healthy 
subjects. The QSM based CMRO2 was compared with an 𝑅𝑅2∗ based  CMRO2 to analyze the 
regional consistency within cortical gray matter (CGM) with the scaling in the 𝑅𝑅2∗ method 
set to provide same total CMRO2 as the QSM method for each subject. 
Results 
Compared to pre-caffeine, susceptibility increased (5.1±1.1ppb, p<0.01) and CBF 
decreased (-23.6±6.7ml/100g/min, p<0.01) at 25min post-caffeine in CGM. This 
corresponded to a CMRO2 R of 153.0±26.4µmol/100g/min with an OEF of 33.9±9.6% and 
54.5±13.2% (p<0.01) pre- and post- caffeine respectively at CGM, and a CMRO2 R  of 
58.0±26.6µmol/100g/min at white matter. CMRO2 from both QSM and 𝑅𝑅2∗ based methods 
showed good regional consistency (p>0.05), but quantitation of R2∗  based CMRO2 required 
an additional scaling factor. 
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Conclusion 
QSM can be used with perfusion measurements pre- and post- caffeine 
vascoconstriction to map CMRO2 and OEF.  
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4.2    INTRODUCTION: CLINICAL CHALLENGES AND PRIOR WORK 
The cerebral metabolic rate of oxygen (CMRO2) and the oxygen extraction fraction 
(OEF) are important markers for assessing neuronal viability in ischemic stroke when 
hypoperfusion leads to a compensatory OEF  increase to maintain oxygen metabolism 
before the onset of brain tissue infarction (1-3). Positron emission tomography (PET) 
using 15O has been used to map CMRO2, but its feasibility as a clinical tool is severely 
limited by the short half-life (123 sec) of 15O (4) and sparse availability compared to other 
imaging modalities like MRI.  
When oxygen is released from arterial blood to brain tissue, the weakly diamagnetic 
oxyhemoglobin (oHb) turns into to the strongly paramagnetic deoxyhemoglobin (dHb) in 
the draining veins (5). MRI is very sensitive to this change in magnetic susceptibility. 
Changes in R2  (estimated from spin echo data) and R2∗  (estimated from gradient echo 
(GRE) data) by the magnetic field of dHb have been used to estimate dHb concentration ([dHb]) (6-11). As R2∗  is more sensitive than R2  (12), R2∗  is more commonly used (13-15). 
However, R2∗  images are contaminated by blooming artifacts and are highly dependent on 
imaging parameters including field strength, echo time, voxel size, and object orientation 
(6,16), making it difficult to quantitatively map [dHb].  
Because [dHb]  is linearly related to blood magnetic susceptibility that is 
independent of imaging parameters (17,18), quantitative susceptibility mapping (QSM) 
derived from the magnitude and phase of the GRE signal (19-35) has the potential for 
quantitative [dHb]  measurements. QSM may provide an advantage over the previous 
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approaches by eliminating the blood vessel geometry dependence in estimating [dHb] in 
veins only (36-40). Here, we demonstrate the feasibility of CMRO2 mapping using QSM 
and cerebral perfusion measurements. 
 
4.3    SUSCEPTIBILITY MODELING OF TISSUE AND BLOOD 
 
According to mass conservation, we have,  
CMRO2 = 4CBF ∙ ([dHb]v − [dHb]a)   [4.1] 
Here CBF is the volumetric cerebral blood flow rate, and [dHb]v and [dHb]a are [dHb] in 
the draining veins and supplying arteries respectively. The factor 4 accounts for the four 
oxygen molecules in one oHb, each bound to one of four hemes. CBF can be measured 
using a quantitative perfusion technique such as arterial spin labeling (ASL) (41). The 
arterial dHb concentration can be written as [dHb]a = (1 − SaO2)[Hb]  with arterial 
oxygen saturation SaO2 = 0.97 and hemoglobin concentration [Hb] = 2.48µmol/ml for 
healthy subjects (see Appendix). [dHb]v  can be derived using QSM in the following 
manner by carefully accounting for contributions from various components in blood and 
non-blood tissue weighted by the respective volume fractions, though the dominant 
contributions are from venous dHb and tissue ferritin.  
 The voxel susceptibility, 𝜒𝜒, in QSM is linearly proportional to [dHb]v, 
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𝜒𝜒 = CBVv ∙ ΨHb(XdHb − XoHb) [dHb]v[Hb] + χo.   [4.2] 
Here CBVv = 0.5CBV is the venous blood volume fraction in a voxel assuming blood 
deoxygenates linearly (10). ΨHb = 0.12 is the volume fraction of Hb within blood (see 
Appendix). XdHb = 10765ppb and XoHb = −813ppb are the volume susceptibilities of 
pure dHb and oHb respectively (see Appendix). The first term in the right hand side of Eq. 
4.2 reflects the susceptibility contribution from venous dHb relative to oxygenated blood. 
The second term χo in Eq. 4.2 reflects susceptibility contributions from non-blood tissue 
sources (such as ferritin) χt, pure oxygenated blood Xba, and arterial deoxyhemoglobin: 
χo = (1 − CBV)χt + CBV ∙ Χba + CBVa ∙ ΨHb(XdHb − XoHb) [dHb]a[Hb] ,          [4.3] 
with CBVa = 1 − CBVv = 0.5CBV, and Χba = ΨHb ∙ XoHb + (1 −ΨHb)Xp = −131ppb is 
the volume susceptibility for pure oxygenated blood (Xp = −37.7ppb is blood plasma 
volume susceptibility) (18,39,42).  
With susceptibility (𝜒𝜒) and perfusion (CBV and CBF) measurements, Eqs.1&2 form 
an equation with two unknowns (CMRO2 and χo ): 
CMRO2 = 4CBF ∙ [Hb]� 𝜒𝜒−χo CBVv∙ΨHb(XdHb−XoHb) − (1 − SaO2)�.   [4.4] 
To determine CMRO2, it is necessary to correct for χt, which is independent of blood. This 
can be achieved using measurements at two different brain perfusion states that have the 
same CMRO2, such as before and after vasoconstriction in a caffeine challenge (43-45). It 
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is reasonable to assume the non-blood contribution (1 − CBV)χt to susceptibility in a voxel 
to be the same between the two states. Then Eq. 4.4 leads to 
CMRO2 = 4[Hb]Δ(CBVv/CBF)� ∆𝜒𝜒−∆χ0ΨHb(XdHb−XoHb) − ΔCBVv(1 − SaO2)�                        [4.5] 
where ∆  denotes the difference between the two measurements (see Appendix for a 
detailed derivation of Eq. 4.5 from Eq. 4.4). 
OEF is defined as the oxygen concentration difference between artery and vein 
scaled by the arterial oxygen concentration (4 ∗ SaO2[Hb] = 4 ∗ 0.97[Hb]) can then be 
determined as 
OEF = CMRO2
4∙SaO2∙[Hb]∙CBF                                          [4.6] 
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4.4    EXPERIMENTS AND ANALYSIS 
 
The study was approved by the local Institutional Review Board. Healthy volunteers 
were recruited (n=13, 13 males, mean age 35 ± 9.5 years) for brain MRI on a 3T scanner 
(HDxt, GE Healthcare, Waukesha, WI, USA) using an 8-channel receive head coil. All 
subjects were instructed to avoid caffeine or alcohol intake 24 hours prior to MRI.   
 
4.4.1    Data Acquisition 
Given its well-described ability to safely cause measurable reductions in CBF within 
30 minutes upon administration (45), a bolus of caffeine (~200 mg caffeine in black coffee) 
was administered orally through a flexible plastic tube to minimize head motion. MRI was 
performed before and 25 min after the oral administration of the caffeine challenge, using 
a protocol consisting of an anatomical T2 weighted 2D fast spin echo (FSE) sequence, a 
3D FSE ASL sequence to measure CBF, and a 3D spoiled GRE sequence to measure 
magnitude and phase, from which QSM maps were calculated using dipole inversion 
algorithm (19,21). The total scan time was approximately 60 min (consisting of 15 min 
scan before caffeine administration to 45 min after). 
The T2 weighted axial 2D FSE parameters were: 82 ms TE, 4250 ms TR, 22 cm 
FOV, 0.46 x 0.46 mm2 in-plane resolution, 3mm slice thickness, 46 slices, 23 echo train 
length (ETL), 2 signal averages, and 5 min scan time.  
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The 3D FSE ASL sequence parameters were: 1500 ms labeling period, 1525 ms 
post-label delay, spiral sampling of 8 interleaves with 512 readout points per leaf, 62.5 kHz 
readout bandwidth, 1 ETL,  3 mm isotropic resolution and identical volume coverage as 
the T2 weighted sequence, 10.5 ms TE, 4796 ms TR, 3 signal averages, and 6 min scan 
time. CBF maps (ml/100g/min) were generated from the ASL data using the FuncTool 
software package (GE Healthcare, Waukesha, WI, USA).  
The 3D spoiled GRE sequence parameters included: 11 equally spaced echoes, 4.4 
ms first TE, 4.9 ms echo spacing , 58.5 ms TR, 0.46 mm in-plane resolution, 3 mm slice 
thickness, and identical volume coverage as the T2 weighted sequence, 62.5 kHz readout 
bandwidth, 15o flip angle, and 7 min scan time. The pulse sequence was flow-compensated 
in the readout (anterior-posterior) direction. 
 
4.4.2    Image Processing  
QSM maps were calculated from GRE magnitude and phase data. A Gauss-Newton 
nonlinear estimation of the field map was performed (33), followed by unwrapping (46) 
and background field removal using a projection onto dipole fields method (47) to obtain 
the local field map, from which tissue susceptibility was computed using the Morphology 
Enabled Dipole Inversion (MEDI) algorithm (20,33). R2∗  maps were generated from GRE 
magnitude data via voxel-by-voxel fitting using auto-regression on linear operations 
(ARLO) monoexponential fitting algorithm (48). Signal-to-noise ratio (SNR) of QSM and 
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R2∗  maps were estimated as the ratio of mean over standard deviation of values measured 
in the caudate nucleus. 
Grey matter (GM) and white matter (WM) masks were created using the FSL FAST 
algorithm on pre-caffeine CBF images covering the supratentorial brain parenchyma from 
the vertex to the superior aspect of the cerebellum (49). These masks were visually 
confirmed by a board-certified attending neuroradiologist (A.G.) for anatomical accuracy. 
The cortical GM mask was further segmented by the same neuroradiologist into six 
vascular territories (VT, left and right anterior cerebral artery (ACA), middle cerebral 
artery (MCA) and posterior cerebral artery (PCA)) (Fig. 4.1). For this feasibility study, pre-
caffeine CBV was estimated from CBF based on the linear regression equations derived 
from 15O steady-state inhalation PET (50): CBV = (0.227CBF − 7.27)/100 within the 
GM mask, and CBV = (0.0316CBF + 1.9447)/100 within the WM mask. Post-caffeine CBV was estimated from pre-caffeine CBV using Grubb’s exponent of α = 0.38 (51) for 
both masks. CMRO2  maps of GM and WM were then calculated from pre- and post-
caffeine QSM and CBF/CBV  measurements by solving Eq. 4.4 using a conjugate gradient 
method. The resulting maps were combined to obtain the final  CMRO2 maps of the whole 
brain. OEF maps were then calculated using Eq. 4.8. Gaussian smoothing (2.1 mm kernel) 
was used to reduce noise in the CMRO2 and OEF maps.  
All images were co-registered and interpolated to the resolution of the CBF maps 
using the FSL FLIRT algorithm (52,53). QSM values were referenced to the susceptibility 
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of water (defined in this study as the mean susceptibility of cerebrospinal fluid (CSF) in 
the lateral ventricles).   
 
 
 
 
 
 
 
 
 
Figure 4.1. Example of GM and WM masks on a mid-brain slice. The GM mask is 
segmented into six regions corresponding to different vascular territories as shown. The 
masks cover the supratentorial brain parenchyma from the vertex to the superior aspect of 
the cerebellum.  
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CMRO2 was also estimated using a calibrated fMRI approach based on R2∗  (13-15). 
The difference in R2∗  between pre- and post- caffeine challenge can be used to estimate the 
dHb component of R2∗  in a voxel during pre-caffeine state (R2∗ |dHb,pre) according to the 
following equation with Grubb’s α = 0.38 and an empirical β = 1.5 (54).  
R2,pre∗ − R2,post∗ = R2∗ |dHb,pre �1 − �CBFpostCBFpre �α−β�.                            [7] 
Then the relationship between R2∗ |dHb,pre  and pre-caffeine venous dHb concentration [dHb]v,pre is given as follow (7,8,11,54,55): 
R2∗ |dHb,pre = A ∙ CBVpre[dHb]v,preβ     [8] 
Combining Eqs.7&8 with Eq. 4.1 and using 0][ ≈adHb  and (CBFpostCBFpre )α = CBVpostCBVpre , we have 
 CMRO2 = 4A−1/β ∙ CBFpreCBFpost � R2,post∗ −R2,pre∗CBVpostCBFpreβ −CBVpreCBFpostβ �1/β.                    [9] 
This R2∗  based CMRO2 method requires the scaling factor A to be measured separately with 
an additional measurement at a different brain state (13-15). For this feasibility study, the 
regional consistency of CMRO2 maps within cortical GM ROIs (Fig. 4.1) derived from 
QSM and 𝑅𝑅2∗ based methods was compared under the assumption that their global averages 
or total CMRO2 were the same for each subject, which allowed A to be determined from 
the QSM data without further experiment. 
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4.4.3    Statistical Analysis 
For each ROI, the mean and standard deviation of QSM, CBF, OEF, and CMRO2 
values as well as the corresponding left/right (L/R) hemisphere ratio were measured for 
both the QSM based and R2∗  based method. Paired-sample t-tests were performed to assess 
the differences in QSM, R2∗ , CBF, and OEF in the GM ROIs before and after the caffeine 
challenge across the subjects. PET studies have shown that CMRO2 and OEF maps are 
homogeneous in GM across the brain and exhibit left-right symmetry in healthy subjects 
(50,56). Paired-sample t-tests were performed to compare CMRO2 R in the VT ROIs between 
QSM based and R2∗  based method to analyze their consistency. To analyze the symmetry 
of the images, analysis of variance (ANOVA) was performed to assess the significance of 
differences in L/R hemisphere ratio of CMRO2 and OEF among the VT ROIs. P values of 
less than 0.05 were considered to indicate statistical significance. All data were expressed 
as mean ± standard deviation. 
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4.5    RESULTS  
All scans were completed successfully. The average GM volume for each vascular 
territory was 125.8 ± 17.7 mL (ACA, both left and right), 254.0 ± 25.4 mL (MCA), and 
79.7 ± 14.2 mL (PCA) (n=13). Figure 4.2 shows an example of pre- and post-caffeine QSM 
and CBF maps and the calculated CMRO2 and OEF  maps. QSM and R2∗  maps have similar 
SNR (6.2 ± 1.9 vs. 7.2 ± 1.6, p>0.05). Figure 4.3 shows OEF and CMRO2 maps across the 
brain volume, illustrating good GM and white matter contrast in reasonable agreement with 
T2 weighted images. Compared to the pre-caffeine values, a statistically significant 
increase in QSM (5.1 ± 1.1 ppb, p<0.01), R2∗  (1.5 ± 0.3 s−1, p<0.01), and decrease in CBF 
(-23.6 ± 6.7 ml/100g/min, p<0.01) were measured in the global cortical GM ROI at 25 min 
post-caffeine. Consistent with the decrease in CBF  after the caffeine challenge, OEF 
significantly increased from 33.9 ± 9.6% to 54.5 ± 13.2% (p<0.01) at 25 min post-caffeine. 
The mean CMRO2 R in the global cortical GM ROI calculated using QSM were 153.0 ± 26.4 
µmol/100g/min. The mean CMRO2, and pre- and post-caffeine OEF measured in the WM 
were 58.0 ± 26.6 µmol/100g/min, 26.3 ± 11.7% and 45.0 ± 18.7%, respectively.  
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Figure 4.2. An example of QSM and CBF maps acquired pre- and post-caffeine and the 
derived CMRO2 and OEF maps in a healthy subject (subject 12).  
 
Figure 4.4 compares CMRO2 maps obtained from two other subjects using QSM-
based and R2∗ -based methods. The mean R2∗ |dHb,pre in the global cortical GM ROI was 1.9 
± 0.8 s−1. Table 4.1 shows the CMRO2 measured within VT ROIs of QSM based and R2∗  
based methods, demonstrating good agreement within all vascular territories (all 
differences were statistically non-significant). Table 4.2 shows the L/R hemisphere ratio 
of CMRO2 and OEF measured within the VT ROIs. Both the QSM and R2∗  method show 
statistically comparable L/R hemisphere ratio values among vascular territories ranging 
from 0.92 to 1.07, indicating good hemispheric symmetry. (ANOVA, p > 0.05). 
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Figure 4.3. An example of volumetric pre- and post-caffeine OEF and CMRO2 maps using 
the QSM-based method, and T2 weighted images of a healthy subject (subject 7). The 
locations of the slices are marked on the scout images shown on the right. 
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Table 4.1: QSM and R2∗  based CMRO2  measurements within cortical GM regions 
associated with different vascular territories (µmol/100g/min, mean ± std). All differences 
between the two methods were statistically non-significant (p>0.05). 
 QSM based R2∗  based 
ACA_Left 175.5 ± 33.4  166.2 ± 29.9 
ACA_Right 174.1 ± 33.6 160.6 ± 29.5 
MCA_Left 149.3 ± 27.1 153.2 ± 42.1 
MCA_Right 154.8 ± 37.7 144.8 ± 33.6 
PCA_Left 143.9 ± 38.0 159.1 ± 39.8 
PCA_Right 140.8 ± 32.8   157.0 ± 38.3 
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Table 4.2: L/R hemisphere ratio of QSM and R2∗  based CMRO2 and OEF values measured 
within cortical GM regions. No statistical significance has been found (p>0.05) among 
vascular territory within each method. 
 OEF Pre-Caffeine OEF Post-Caffeine CMRO2 
QSM based R2* based QSM based R2* based QSM based R2* based 
ACA 0.99 ± 0.12  1.00 ± 0.13  0.99 ± 0.13  1.02 ± 0.15  1.03 ± 0.21  1.04 ± 0.15  
MCA 0.99 ± 0.25  0.99 ± 0.23  0.97 ± 0.24  0.97 ± 0.26 1.00 ± 0.22  1.07 ± 0.23 
PCA 0.94 ± 0.13  0.96 ± 0.19  0.92 ± 0.13 0.92 ± 0.15 1.03 ± 0.15  1.03 ± 0.23  
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4.6    DISCUSSION 
 
Our preliminary results demonstrate the in vivo feasibility of 3D CMRO2 R  brain 
mapping using the recently developed QSM and quantitative perfusion. The QSM based CMRO2 of 153.0 ± 26.4 µmol/100g/min in cortical GM agrees well with values reported in 
the MRI and PET literature (13-15,50,56). The QSM based CMRO2 is consistent with the R2∗  based CMRO2  (our mean R2∗ |dHb,pre  of 1.9 ± 0.8 s−1 is in agreement with values in 
calibrated fMRI literature (13,57-60)). Using measurements at two different brain states 
(pre- and post- caffeine challenge here), the QSM based CMRO2  method can provide 
absolute quantitation while the *2R  based CMRO2  method relies on the additional 
measurement of a scaling factor. 
The R2∗  model for blood oxygenation level-dependent (BOLD) signal (Eqs.7&8) 
have been used extensively to study neural function and oxygen metabolism in calibrated 
fMRI (13-15,55,61). For quantitation of venous dHb concentration [dHb]v required for CMRO2 , the R2∗  model determines [dHb]v  up to a constant A (Eqs.7&8), which is a 
disadvantage compared to the absolute quantitation of [dHb]v by the QSM based method 
(Eq. 4.2). This may be explained by the underlying physics for R2∗  and QSM. QSM solves 
the field to susceptibility source inverse problem based on Maxwell’s equation (21) using 
the phase of the gradient echo data. Magnetic susceptibility has a well-defined quantitative 
relationship with [dHb]v (Eq. 4.2). On the other hand, R2∗  is the decay rate of gradient echo 
magnitude signal and may be approximated as the variance of the field in a voxel (6,34,62). 
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Its relationship with [dHb]v  is empirical and depends on a scaling factor that requires 
additional information to be determined (8,11,55). The calculation of the field variance 
requires input of detailed field pattern in a voxel that is not known, which is the 
fundamental cause of this indeterminacy of the R2∗  model. Measurements at a third brain 
state can estimate this scaling factor, which is why 3 brain states (normoxic, hyperoxic and 
hypercapnia) have been used in R2∗  based CMRO2  mapping (13-15). Additionally, the 
empirical parameter β~1.5 may be spatially varying (63), as β~1 for voxels containing 
larger vessels (6) and β~2 for voxels containing capillaries (7,61). This may explain the 
greater difference between QSM and R2∗  based CMRO2 measurements in regions with large 
vessels such as the posterior region near the large sagittal sinus (PCA in Table 4.1). 
Furthermore, Eqs.7&8 may not properly account for the ferritin (non-heme iron) 
contribution to R2∗ , possibly causing overestimation of CMRO2 in the basal ganglia area 
with known high ferritin concentration (Fig. 4.4c).  Besides requiring fewer drug 
challenges, QSM based CMRO2 offer other potential benefits such as reduced blooming 
artifacts near the air-tissue interface and improved robustness against changes in scanning 
parameters (64).  
The voxel size used in this work was chosen mainly based on scan time and SNR 
considerations. In general, SNR is dictated by scan time, which in this study was kept 
comparable to that used in routine MRI (6 min for 3D ASL (65) and 7 min for QSM (66)) 
with the aim to prevent head motion and also to keep the total experiment time under 1 
hour. As a result, the achievable spatial resolution for the ASL scan was 3 mm isotropic, 
which is lower than that of the QSM scan (0.5x0.5x3 mm3). The derived CMRO2 and OEF 
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maps therefore also have a 3 mm isotropic resolution, although due to the very small change 
in the observable MR signal between the two brain states we found that reliable quantitative 
analysis can be performed only with region-based (instead of voxel-based) measurements. 
This is a limitation of the current work and solutions for SNR improvement require further 
investigation. 
In this work, several physiological parameters such as arterial oxygenation 
saturation level (SaO2) and total hemoglobin concentration (ΨHb = 0.12) were assumed 
fixed for all subjects (see Appendix). In clinical practice, these parameters can be measured 
for each individual subject using highly automated devices: SaO2 can be obtained through 
pulse oximetry (67), and ΨHb can be measured directly using hemoximetry or estimated 
from hematocrit measurement. In healthy subjects, SaO2 and ΨHb can range from 0.95 to 
0.99 and 0.096 to 0.14 (68). Within these ranges, error propagation analysis showed a 
worst-case deviation of 11% from CMRO2 obtained in GM with fixed SaO2 and ΨHb 
values, which suggests that our method is fairly robust against changes in these 
physiological parameters.   
While previous works have reported similar OEF over the whole brain (69,70), we 
found that OEFs were slightly lower in WM than in GM (26.3 ±11.7% vs. 33.9 ± 9.6% 
pre-caffeine, and 45.0 ± 18.7% vs. 54.5 ± 13.2% post-caffeine, p<0.05). The observed 
discrepancy between WM and GM regions may be attributed to the challenges associated 
with accurately mapping the relationship between CBF and CBV in each region, which 
was derived empirically from normative PET data (50). A separate measurement of CBV 
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may be performed using a dynamic susceptibility contrast, or a dynamic QSM method (71) 
and extracellular contrast agents that clear rapidly before the administration of caffeine, 
unless it is performed as the last scan. 
In this work, CSF was used to provide the reference value for brain parenchymal 
susceptibility. To overcome the effect of CSF flow, our GRE pulse sequence was flow-
compensated in the readout (anterior-posterior) direction. When compared to a fully 
compensated pulse sequence (72) in three of our subjects, we found that the difference in 
susceptibility of the CSF (measured in lateral ventricles) was relatively small (4.1 ± 3.7 
ppb, p>0.05) . Further work is needed to study the effect of CSF flow on QSM and CMRO2 
accuracy. 
Caffeine administration has been shown to have no significant change in CMRO2 
(45). Other CMRO2-invariant brain challenges may include hypercapnia and hyperoxia, 
which may have risks and discomforts associated with the prolonged (>10min) continuous 
inhalation of high concentration CO2 and O2 necessary for the data acquisition. In addition, 
this feasibility study lacks the second challenge for estimating coefficient A in calibrated 
BOLD. Further work is warranted to compare the proposed QSM-based with the existing R2∗  based methods that include the additional hyperoxia or hypercapnia challenges.  
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4.7    CONCLUSION 
Quantitative susceptibility mapping can be used in conjunction with cerebral 
perfusion measurements before and after a vasoconstricting caffeine challenge to map 
cerebral metabolic rate of oxygen consumption and oxygen extraction fraction. 
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4.8    APPENDIX 
Here we provide detailed derivation of Eq. 4.5 from Eq. 4.4 and estimation of parameters 
related to blood. 
Derivation of Eq. 4.5 from Eq. 4.4 
Eq. 4.4 is CMRO2 = 4CBF ∙ [Hb]� 𝜒𝜒−χo CBVv∙ΨHb(XdHb−XoHb) − (1 − SaO2)�          [4.4] 
Moving 𝜒𝜒 − χo to the left side, we have: 
𝜒𝜒 − χo = ΨHb(XdHb − XoHb)�CMRO24[Hb] ∙ CBVvCBF + CBVv(1 − SaO2)�      [4.4a] 
 
Equation 4a applies to each of the two brain states (pre- and post-caffeine), the difference 
of which can be written as: 
 
∆𝜒𝜒 − ∆χo = ΨHb(XdHb − XoHb)�CMRO24[Hb] ∙ ∆ �CBVvCBF � + ∆CBVv(1 − SaO2)� [4.4b] 
 
By rearranging  Eq. 4.4b, we arrive at Eq.4.5: CMRO2 = 4[Hb]Δ(CBVv/CBF)� ∆𝜒𝜒−∆χ0ΨHb(XdHb−XoHb) − ΔCBVv(1 − SaO2)�  [4.5] 
 
Calculation of hemoglobin molar concentration in blood [Hb] 
The hemoglobin molar concentration in blood [Hb] = 2.48 µmol/ml, is estimated 
from the Hematrocrit Hct = 0.47 (68), Hb mass concentration in a RBC (0.34 g/ml) , and 
the molar mass of dHb MHb = 64450 × 10−6 g/µmol (73). 
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[Hb] = Hct ∙ 0.34 g/mlMHb = 2.48 µmol/ml 
 
Calculation of hemoglobin volume fraction in blood in blood HbΨ  
The hemoglobin volume fraction in blood ΨHb = 0.12 is estimated from [Hb], MHb, 
and Hb concentration in pure aggregate (ρHb = 1.335g/ml) (74). 
ΨHb = [Hb] ∙ MHbρHb = 0.12 
Calculation of oxyhemoglobin 𝐗𝐗𝐨𝐨𝐨𝐨𝐨𝐨  and deoxyHemoglobin 𝐗𝐗𝐝𝐝𝐨𝐨𝐨𝐨  volume 
susceptibility 
The volume susceptibility of oxyhemoglobins XoHb relative to water is estimated from the 
reported mass susceptibility of globin relative to vacuum, -4π  (0.587×10–6 mL/g) (4π  for 
conversion from cgs to si) (74,75) as, 
XoHb = (−4π(0.587 × 10−6 ml/g)ρHb) − (−9035 ppb) = −813 ppb 
where ppb9035−  is the volume susceptibility of water with respect to vacuum (76). 
The volume susceptibility of oxyhemoglobins XdHb  relative to water is estimated by 
adding to XoHb  a paramagnetic term of 5.25 µB (Bohr magneton µB = 9.274 × 10−24 J/T) 
per heme (77,78) according to (18,34,79), 
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XdHb = 4 NAρHbµ0(5.25µB)23MHbkBT + XoHb = 10765 ppb 
where NA = 6.02 × 1023 mol−1  is the Avogadro number, µ0 = 4π × 10−7 Tm/A is the 
magnetic permeability in vacuum, kB = 1.38 × 10−23 J/K is the Boltzman constant, and T = 310 K is the human body temperature. 
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Chapter 5 
 
 
 
 
Improving Signal-To-Noise Ratio (SNR) and Practicality of QSM-
based CMRO2 Mapping With Priors and Hyperventilation 
Challenge  
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5.1    ABSTRACT 
Purpose 
Our objective was to demonstrate the feasibility of using hyperventilation as an 
efficient vasoconstrictive challenge and prior knowledge as denoising constraints for 
cerebral metabolic rate of oxygen (CMRO2) mapping based upon quantitative 
susceptibility mapping (QSM). 
Methods 
3D multi-echo gradient echo and arterial spin labeling imaging were performed to 
calculate QSM and perfusion maps before and after a hyperventilation challenge in 11 
healthy subjects. For comparison, this was repeated using a caffeine challenge. Whole brain 
CMRO2 and oxygen extraction fraction (OEF) maps were computed using constrained 
optimization. Hyperventilation scans were repeated to measure reproducibility. Regional 
agreement of CMRO2 and OEF maps was analyzed within the cortical gray matter (CGM) 
using t-test and Bland-Altman plots. 
Results 
Hyperventilation challenge eliminates the 30 min waiting time needed for caffeine 
to exert its vaso-constrictive effects. Mean CMRO2 (in µmol/100g/min) obtained in CGM 
using the caffeine and repeated hyperventilation scans were 149±16, 153±19, and 150±20 
respectively. This corresponded to an OEF of 33.6±3.4%, 32.3±3.2%, and 34.1±3.8% at 
baseline state and 39.8±4.8%, 43.6±6.2% and to 42.8±6.8% at challenged state, 
respectively. Hyperventilation scans produced a good agreement of CMRO2 and OEF 
values. 
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Conclusion 
Hyperventilation is a feasible, reproducible and efficient vasoconstrictive challenge 
for QSM based quantitative CMRO2 mapping.  
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5.2    INTRODUCTION 
The quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) and 
oxygen extraction fraction (OEF) has long been sought after in both research and clinical 
settings as important indicators for neural viability and activity (1-3). As oxygen is released 
to brain tissue, the weakly diamagnetic oxyhemoglobin (oHb) turns into to the strongly 
paramagnetic deoxyhemoglobin (dHb) and induces magnetic field inhomogeneity 
detectable by MRI (4,5). CMRO2 mapping techniques based on MRI include: 1) 
quantitative imaging of extraction of oxygen and tissue consumption (QUIXOTIC) (6) to 
map brain oxygen consumption from the transversal relaxation rates R2 of venous blood. 
QUIXOTIC uses venular-targeted velocity-selective spin labeling technique but has 
limitations including the difficulty in selecting cutoff velocity and outflow time for 
targeting venular blood flow, the imperfection of velocity selection profile and T1 nulling 
of arterial blood and the prolong scan time (~30 minutes). 2) calibrated fMRI approaches 
by modeling R2* in blood oxygen level dependent (BOLD) contrast and by combining with 
hyperoxia and hypercapnia (7-9). These techniques are challenging to implement because 
they require precise gas manipulation and data acquisitions in three brain states. 3) 
estimation of dHb concentration ([dHb]) by modeling R2’ from asymmetric spin echo data 
(10,11) or by separating R2 and R2’ contribution to R2* in 3D multi gradient echo data 
(12). However, accurate R2’ fitting from gradient echo data requires dense sampling of the 
early signal decay curve and may be prone to noise propagation (13). In addition, R2* 
images are subject to blooming artifacts surrounding high susceptibility sources (such as 
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veins) and are highly dependent on imaging parameters including field strength, echo time, 
voxel size, and object orientation (14,15).   
Unlike R2 and R2*, [dH] is linearly related to blood magnetic susceptibility that is 
independent of imaging parameters (16,17). Quantitative susceptibility mapping (QSM) 
derived from the complex GRE signal (18-21) can be used to quantify blood oxygenation 
in veins (22-26) and brain tissues (27). CMRO2 and OEF maps can be computed using 
QSM and arterial spin labeling (ASL) data acquired in two brain states, such as before and 
after an acetazolamide or caffeine challenge in healthy subjects (27). However, these 
challenges would add a substantial waiting time on top of the MRI acquisition time. For 
example, the coffee challenge requires an additional 30 minutes for the caffeine to exert its 
maximal vaso-constrictive effects. Similarly, acetazolamide challenge requires 15 minutes 
to exert its maximal vasodilatory effect and is limited by potential adverse effects of drug 
administration (28). Another issue with the previous reconstruction method (27) is that the 
generated CMRO2 and OEF maps are quite noisy. 
Hyperventilation is known to reduce partial pressure of carbon dioxide (CO2) in 
arterial blood and can cause 40% decrease of cerebral blood flow within minutes without 
significantly changing CMRO2 (29,30), therefore, even though hyperventilation might 
induce minor discomforts in subjects, it can be used with QSM to generate fast CMRO2 
mapping. Additionally, prior knowledge may be used to denoise CMRO2 and OEF maps. 
Accordingly, the purpose of this study was to use hyperventilation as an efficient 
vasoconstrictive and constrained optimization for quantitative CMRO2 mapping. 
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5.3    BAYESIAN APPROACHES FOR SNR IMPROVEMENT  
 
CMRO2 and OEF Reconstruction 
According to mass conservation, 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶2 can be expressed as   
 CMRO2 = CBF ∙ ([𝑑𝑑𝑑𝑑]𝑣𝑣 − [𝑑𝑑𝑑𝑑]𝑎𝑎) [5.1] 
where CMRO2 is cerebral metabolic rate of oxygen (µmol/100g/min), CBF is cerebral 
blood flow (ml/100g/min) measured using ASL, [𝑑𝑑𝑑𝑑]𝑣𝑣 and [𝑑𝑑𝑑𝑑]𝑎𝑎 are deoxyheme molar 
concentration (µmol/ml) in venous and in arterial blood respectively.  
OEF can be expressed as  OEF = [𝑑𝑑𝑑𝑑]𝑣𝑣−[𝑑𝑑𝑑𝑑]𝑎𝑎[𝑑𝑑]−[𝑑𝑑𝑑𝑑]𝑎𝑎                                                                    [5.2] 
Where [𝑑𝑑] = 7.53 µmol/ml is heme molar concentration in tissue blood assuming a tissue 
blood hematocrit (Hct) of Hct𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 = 0.357 , which is estimated from an assumed 
hematocrit of Hct𝑡𝑡𝑡𝑡 = 0.47 in the straight sinus and a Hct ratio of 0.759 between large 
vessel and brain tissue (31). (See appendix for detailed derivation of [𝑑𝑑] ). [𝑑𝑑𝑑𝑑]𝑎𝑎 =0.02 [𝑑𝑑] = 0.15 µmol/ml assuming 98% arterial oxygenation.   
 [𝑑𝑑𝑑𝑑]𝑣𝑣 in Eq. 5.2 can be mapped using QSM (27). The voxel susceptibility, 𝜒𝜒, in QSM can 
be expressed as a volume weighted sum of susceptibility contribution from arterial and 
venous blood, and non-blood tissue: 
χ = CBVv ∙ 𝑋𝑋𝑑𝑑𝑑𝑑,𝑚𝑚𝑚𝑚𝑚𝑚 ∙ [𝑑𝑑𝑑𝑑]𝑣𝑣 + χnb + χ0.                             [5.3] 
The first term in the right side of Eq. 5.3 reflects the susceptibility contribution from venous 
dH. CBVv = 0.77CBV is the venous blood volume fraction in a voxel (32), CBV is the total 
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blood volume fraction in a voxel (see below), XdH,mol =  151.054 ppb 𝑚𝑚𝑚𝑚𝜇𝜇𝑚𝑚𝑚𝑚𝑚𝑚 is the molar 
magnetic susceptibility of dH (16,17).  
The second term χnb reflects susceptibility contributions from non-blood tissue sources 
(such as ferritin). 
The third term χo in the right side of Eq. 5.3 reflects susceptibility contributions from pure 
oxygenated blood Xba, and arterial deoxyheme: 
χo = CBV ∙ Χba + CBVa ∙ 𝑋𝑋𝑑𝑑𝑑𝑑,𝑚𝑚𝑚𝑚𝑚𝑚 ∙ [𝑑𝑑𝑑𝑑]𝑎𝑎,                          [5.4] 
with CBVa = CBV − CBVv = 0.23CBV is the arterial blood volume fraction in a voxel (32), 
and Χba is is the volume susceptibility for pure oxygenated blood, 
Χba = 𝑑𝑑𝐻𝐻𝐻𝐻𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡δHb ∙ XoHb + (1 − 𝑑𝑑𝐻𝐻𝐻𝐻𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡δHb)Xp = −108.3 ppb 
Where XoHb = −813 ppb and Xp = −37.7 ppb are the oxyhemoglobin and blood plasma 
volume susceptibility (17,25,33), δHb = 0.255 is the volume fraction of Hb in RBC. See 
Appendix for detailed derivation of  XoHb and δHb. 
Substituting Eq. 5.3 into Eq. 5.1, we obtained the following expressions for CMRO2 
an OEF: 
CMRO2 = 𝐶𝐶𝐶𝐶𝐶𝐶 � 𝜒𝜒−χnb −χ0 CBVv∙𝑋𝑋𝑑𝑑𝑑𝑑,𝑚𝑚𝑚𝑚𝑚𝑚 − [𝑑𝑑𝑑𝑑]𝑎𝑎�                                     [5.5] 
In Eq. 5.5, there are two unknowns: CMRO2 and the non-blood susceptibility 
contribution  χnb . With susceptibility and blood flow measurements of baseline and 
challenged brain states, CMRO2 and subsequently OEF can be calculated by solving Eq. 
5.4 over two brain states. 
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In previous work (27), Eq. 5.5 was solved directly for CMRO2 using a conjugate 
gradient method without constraints, which led to noisy CMRO2 maps. Noise in the 
solution for a large linear system can be reduced by improving the condition number using 
constraints and preconditioning (34). We imposed a physiologically meaningful constraint 
on OEF (0≤OEF≤1) by searching for OEF instead of CMRO2. The OEFs at baseline 
(𝐶𝐶𝑂𝑂𝐶𝐶𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡) and challenge (𝐶𝐶𝑂𝑂𝐶𝐶𝑐𝑐ℎ𝑎𝑎𝑚𝑚) and susceptibility from non-blood tissue sources (such 
as ferritin) χnb were organized into a vector of unknowns 𝑥𝑥 in a linear system 𝐴𝐴𝑥𝑥 =  𝑏𝑏 
format:  
𝐴𝐴 =  �𝐶𝐶𝐶𝐶𝐶𝐶𝑣𝑣,𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡 ∙ 𝑋𝑋𝑑𝑑𝑑𝑑,𝑚𝑚𝑚𝑚𝑚𝑚([𝑑𝑑] − [𝑑𝑑𝑑𝑑]𝑎𝑎) 0 10 𝐶𝐶𝐶𝐶𝐶𝐶𝑣𝑣,𝑐𝑐ℎ𝑎𝑎𝑚𝑚 ∙ 𝑋𝑋𝑑𝑑𝑑𝑑,𝑚𝑚𝑚𝑚𝑚𝑚([𝑑𝑑] − [𝑑𝑑𝑑𝑑]𝑎𝑎) 1
𝐶𝐶𝐶𝐶𝐶𝐶𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡 −𝛾𝛾𝐶𝐶𝐶𝐶𝐶𝐶𝑐𝑐ℎ𝑎𝑎𝑚𝑚 0� 
𝑏𝑏 = �𝜒𝜒𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡 − 𝐶𝐶𝐶𝐶𝐶𝐶𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡 ∙ �Χba + 𝑋𝑋𝑑𝑑𝑑𝑑,𝑚𝑚𝑚𝑚𝑚𝑚 ∙ [𝑑𝑑𝑑𝑑]𝑎𝑎�𝜒𝜒𝑐𝑐ℎ𝑎𝑎𝑚𝑚 − 𝐶𝐶𝐶𝐶𝐶𝐶𝑐𝑐ℎ𝑎𝑎𝑚𝑚 ∙ �Χba + 𝑋𝑋𝑑𝑑𝑑𝑑,𝑚𝑚𝑚𝑚𝑚𝑚 ∙ [𝑑𝑑𝑑𝑑]𝑎𝑎�0 � 
𝑥𝑥 = �𝐶𝐶𝑂𝑂𝐶𝐶𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡𝐶𝐶𝑂𝑂𝐶𝐶𝑐𝑐ℎ𝑎𝑎𝑚𝑚
𝜒𝜒𝑛𝑛𝑏𝑏
�                                                              [5.6] 
Here 𝛾𝛾 is the ratio between global CMRO2 estimated from the straight sinus and CBF maps 
before and after the challenge: 
 𝛾𝛾 = 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶2,𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡𝑔𝑔𝑚𝑚𝑚𝑚𝑏𝑏𝑎𝑎𝑚𝑚
𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶2,𝑐𝑐ℎ𝑎𝑎𝑚𝑚𝑔𝑔𝑚𝑚𝑚𝑚𝑏𝑏𝑎𝑎𝑚𝑚 = ([𝑑𝑑] − [𝑑𝑑𝑑𝑑]𝑎𝑎)𝐶𝐶𝑂𝑂𝐶𝐶𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡𝑣𝑣 𝐶𝐶𝐶𝐶𝐶𝐶𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡,𝚤𝚤�����������([𝑑𝑑] − [𝑑𝑑𝑑𝑑]𝑎𝑎)𝐶𝐶𝑂𝑂𝐶𝐶𝑐𝑐ℎ𝑎𝑎𝑚𝑚𝑣𝑣 𝐶𝐶𝐶𝐶𝐶𝐶𝑐𝑐ℎ𝑎𝑎𝑚𝑚,𝚤𝚤�����������  
 
Here, global cerebral blood flow was estimated by averaging CBF over all brain voxels 
(𝐶𝐶𝐶𝐶𝐶𝐶𝚤𝚤������ ), denoted by 𝑖𝑖   and 𝐶𝐶𝑂𝑂𝐶𝐶𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡𝑣𝑣  and 𝐶𝐶𝑂𝑂𝐶𝐶𝑐𝑐ℎ𝑎𝑎𝑚𝑚𝑣𝑣  were  estimated from the magnetic 
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susceptibility of venous blood in the straight sinus measured in ROIs drawn by a 
neuroradiologist with 10 years’ experience (A.G.) using Eq. 5.3 with 𝐶𝐶𝐶𝐶𝐶𝐶 = 𝐶𝐶𝐶𝐶𝐶𝐶v =100% and 𝜒𝜒𝑛𝑛𝑏𝑏 = 0 as these voxels consisted of venous blood only, and replacing Hct𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 
with 𝑑𝑑𝐻𝐻𝐻𝐻𝑡𝑡𝑡𝑡 = 0.47. We further imposed a global physiological constraint based on the 
expectation that the global CMRO2 calculated from the CMRO2 map should be similar to 
that calculated from global OEF estimated from susceptibility of venous blood in straight 
sinus, and global CBF estimated from CBF maps by summing all voxels covering the 
whole brain according to mass conservation. Lastly, we applied a right preconditioning 
technique (34) to improve convergence speed and reduce error propagation in the solution 
by redefining the system of equations as 𝐴𝐴∗𝑥𝑥∗ = 𝑏𝑏, where 𝐴𝐴∗ = 𝐴𝐴𝐴𝐴 and 𝑥𝑥∗ = 𝐴𝐴−1𝑥𝑥. 𝐴𝐴 =
𝑑𝑑𝑖𝑖𝑑𝑑𝑑𝑑(1,1,𝛼𝛼) where 𝛼𝛼 is a scaling factor chosen such that the elements of 𝑥𝑥∗ have similar 
order of magnitude. Since the blood contribution to voxel susceptibility is relatively small 
due to small CBV (~5%), in this work we set 𝛼𝛼 = max{|𝜒𝜒𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡|, 75𝑝𝑝𝑝𝑝𝑏𝑏}. Accordingly, the 
constrained solution 𝑥𝑥∗ was obtained by minimizing the following cost function using a 
limited-memory Broyden–Fletcher–Goldfarb–Shanno-Bound (L-BFGS-B) algorithm 
(35,36) with physiological bounds on OEF between 0 and 1: 
𝑥𝑥∗ = arg min
𝑥𝑥∗
�
‖𝐴𝐴∗𝑥𝑥∗ − 𝑏𝑏‖2
2 +
𝜆𝜆�𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶2,𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡𝑔𝑔𝑚𝑚𝑚𝑚𝑏𝑏𝑎𝑎𝑚𝑚 − 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶2,𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡,𝚤𝚤�����������������2 + 𝜆𝜆�𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶2,𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡𝑔𝑔𝑚𝑚𝑚𝑚𝑏𝑏𝑎𝑎𝑚𝑚 − 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶2,𝑐𝑐ℎ𝑎𝑎𝑚𝑚,𝚤𝚤�����������������2�      
  [5.7] 
The second and third terms impose the physiological constrain that the global CMRO2 
estimated from CMRO2 maps to be similar to the global CMRO2 estimated from draining 
veins in both baseline and challenged states. GM and WM data were fitted separately to 
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ensure proper convergence for each. 𝜆𝜆 is chosen based on an average value obtained by L-
Curve analysis (37) on three randomly selected subjects. The iteration was terminated when 
the relative residual was less than 0.025%. 
 For this feasibility study, CBVbase was estimated from CBFbase based on a linear 
regression derived from CBF and CBV values in gray and white matter measured using 15O 
steady-state inhalation PET in 34 healthy subjects: CBV = (0.0723 CBF + 1.144)/100 
(38). CBVchal was estimated from CBVbase using Grubb’s exponent of 0.38 (39). Venous 
blood volume was assumed to remain the same after challenges (40,41). 
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5.4    EXPERIMENTS AND ANALYSIS 
 
The study was approved by the local Institutional Review Board and all subjects 
provided written consent prior to imaging. Healthy volunteers were recruited (n=11, 1 
female, mean age 34 ± 12 years) for brain MRI on a 3T scanner (HDxt, GE Healthcare, 
Waukesha, WI, USA) using an 8-channel brain receive coil. All subjects were instructed 
to avoid caffeine or alcohol intake 24 hours prior to MRI.  In this study, SI units are used 
and magnetic susceptibility is relative to water (CSF) unless otherwise stated. 
 
5.4.1    Data Acquisition 
 
5.4.1.1    Caffeine Experiment 
 
MRI was performed before and 25 min after the oral administration of 200 mg 
caffeine using a protocol similar to that described in (27). Briefly, the protocol consists of 
an anatomical T1w BRAVO sequence, a 3D fast spin echo (FSE) arterial spin labeling 
(ASL) sequence to measure CBF, and a 3D multi-echo spoiled gradient echo (SPGR) 
sequence to measure the local fields, from which QSM maps were calculated using the 
MEDI algorithm (42,43).  
The 3D FSE ASL sequence parameters were: 1500 ms labeling period, 1525 ms 
post-label delay, spiral sampling of 8 interleaves with 512 readout points per leaf, 62.5 kHz 
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readout bandwidth, 20 cm FOV, 3 mm isotropic resolution, 35 axial slices, 10.5 ms TE, 
4796 ms TR, 3 signal averages, and 6 min scan time. 
The 3D SPGR sequence parameters included: 7 equally spaced echoes, 4.3 ms first 
TE, 7.9 ms echo spacing , 56.6 ms TR, 0.52 mm in-plane resolution, 2 mm slice thickness, 
identical volume coverage as the 3D FSE ASL sequence, 62.5 kHz readout bandwidth, 
15o flip angle, and 7 min scan time. The pulse sequence was flow-compensated in all three 
directions (44).  
T1 BRAVO sequence parameters were: 2.92 ms TE, 7.68 ms TR, 450 ms prep time, 
1.2 mm isotropic resolution and identical volume coverage as the 3D FSE ASL sequence, 
±19.5 kHz readout bandwidth, 15o flip angle, and 2 min scan time.  
 
5.4.1.2    Hyperventilation Experiment 
 
Subjects from the caffeine experiment were asked to return within a week and 
coached to hyperventilate at a certain pace (1 inhale and exhale every 2~3 seconds) before 
the scans. MRI was performed before and during hyperventilation using a protocol 
consisting of a 3D FSE ASL sequence, and a 3D SPGR sequence. After the base line scan, 
the subjects were instructed to hyperventilate. The scans of challenged state started 30 
seconds into the hyperventilation (HV1). The hyperventilation period lasts about 7 min. 
Proper restrictive padding inside the head coil was used to minimize head motion. 
Extensive monitoring of subject compliance was not performed during this study in healthy 
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subjects but may be advisable for patient studies.  The compliance of a broader population 
will be studied in our future work. 
The volume coverage and scanning parameters for 3D spoiled GRE and 3D FSE 
ASL acquisitions were similar to those used in the caffeine experiment except the voxel 
size were increased to 1.2 mm and 3.5 mm isotropic, respectively, to shorten the scan time 
to 3 min each and improve subject’s comfort during hyperventilation. 
After the scan, subjects were asked to exit the scanner, rest for 30 min, and return 
to the scanner for a repeat hyperventilation experiment (HV2). 
 
5.4.1.3    Signal to Noise Ratio (SNR) Measurement 
 
For quantification of SNR, two 3D FSE ASL and two 3D SPGR sequence were 
performed consecutively on two of the 11 subjects using the parameters from the caffeine 
protocol.  The scans were repeated with parameters used in HV protocol. 
 
5.4.2    Image Processing  
 
5.4.2.1    CBF and QSM Reconstruction CBF maps (ml/100g/min) were generated from the ASL data using the FuncTool 
software package (GE Healthcare, Waukesha, WI, USA). QSM maps were calculated from 
GRE magnitude and phase data. A voxel-based adaptive quadratic-fit of the phase was used 
to obtain robust total field estimation in the presence of bulk flow (21,44), followed by 
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spatial unwrapping (45) and background field removal using a projection onto dipole fields 
method (46) to obtain the local field map. QSM was computed from the local field map 
using the Morphology Enabled Dipole Inversion (MEDI) algorithm (18,20,21,47). 
Susceptibility values in QSMs were referenced to the susceptibility of water (defined in 
this study as the mean susceptibility of cerebrospinal fluid (CSF) measured in the CSF 
masks, see below). All images were co-registered and interpolated to the resolution of the 
QSM maps using the FSL FLIRT algorithm (48,49). 
 
 
 
5.4.2.2    Numerical Simulation 
 
GM and WM binary masks from one of the subjects were used for the simulation 
(See below). OEFbase and OEFchal were set to 35 and 45% respectively for both GM and 
WM.  𝜒𝜒𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡 and 𝐶𝐶𝐶𝐶𝐶𝐶𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡  are set to 20ppb and -10 ppb,  60 and 30 ml/100g/min for GM 
and WM respectively. 𝜒𝜒𝑐𝑐ℎ𝑎𝑎𝑚𝑚 and 𝐶𝐶𝐶𝐶𝐶𝐶𝑐𝑐ℎ𝑎𝑎𝑚𝑚 were then calculated through Eq. 5.6. Gaussian 
noise calculated using SNR of 10 and GM values were added to the entire χ and CBF maps. 
CMRO2 maps were solved with/without constraints. 𝜆𝜆 is chosen based on an average value 
obtained by L-Curve analysis (37). The simulation was repeated for 10 times. SNR of the 
simulation was calculated by dividing the mean over the standard deviation of over the GM 
Mask.  
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5.4.2.3    SNR Measurement 
 
SNR was calculated using the following equation (50): 
𝑆𝑆𝑆𝑆𝐶𝐶 =  √2 𝑆𝑆
𝜎𝜎  
Where S is mean pixel intensity value in a ROI on one of the original images; σ is the 
standard deviation of pixel intensity in a ROI on the subtracted images. SNR was calculated 
in putamen on ASL control images, GRE first echo magnitude images, and in HV CMRO2 
maps reconstructed with /without constraints. 
 
5.4.3    Statistical Analysis 
 
Cortical grey matter (CGM), white matter (WM), and CSF masks were created 
using the FSL FAST algorithm (51) on T1 BRAVO images covering the supratentorial 
brain parenchyma from the vertex to the superior aspect of the cerebellum. These masks 
were visually confirmed by a neuroradiologist (A.G.) for anatomical accuracy. The CGM 
masks with average volume of 246.4 ± 15.9 cm3 were further segmented by the same 
neuroradiologist into the bilateral anterior (ACA), middle (MCA) and posterior cerebral 
artery (PCA) vascular territories (VT) .  
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For each ROI, the mean and standard deviation of QSM, CBF, OEF, and CMRO2 
values were measured for both the caffeine and hyperventilation method. Paired-sample t-
tests were performed to assess the differences in QSM, CBF, and OEF in the CGM before 
and after the caffeine and hyperventilation challenge across the subjects.  
Bland-Altman plots and paired sample t-tests were performed to compare regional 
CMRO2 and OEF obtained in the VTs using caffeine and hyperventilation challenge, as 
well as those obtained with repeated hyperventilation experiments. 
P values of less than 0.05 were considered to indicate statistical significance. All 
data were expressed as mean ± standard deviation. 
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5.5    RESULTS 
 
All MRI data were acquired successfully. No obvious motion artifacts were 
observed in the QSM and CBF maps. The protocol time were 67 ± 19 (including a 30 
minute waiting time), 15 ± 1.5, and 15 ± 1.6 minutes for caffeine, HV1 and HV2 scans, 
respectively. In numerical simulation, the proposed constraint method improved SNR from 
1.90 ± 0.04 to 8.60 ± 0.83 in GM (Fig. 5.1). SNR acquired using the caffeine and HV 
protocols were 143.9 ± 75.6 and 140.5 ± 33.2 respectively for ASL control images, 28.4 ± 
0.47 and 34.7 ± 0.74 for GRE. In subjects, the constrained reconstruction improved SNR 
in the HV CMRO2 maps from 2.16 ± 1.23 to 5.78 ± 1.36 (p<0.01). 
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 Figure 5.1. Numerical simulation results reconstructed with and without constraints 
(SNR=10). The proposed constrained method improves SNR of the CMRO2 images. 
 
For the reconstruction, 𝜆𝜆 (Eq. 5.7) was chosen to be 2.5 × 104. Figure 5.2 shows 
histograms of OEF and CMRO2 maps of a healthy subject reconstructed with and without 
constraints. Figure 5.1 and 5.2 demonstrated that the use of physiological constraints and 
pre-conditioning achieved substantial reduction of noise and extreme values in CMRO2 
and OEF maps compared to previous unconstrained methods (27).  
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 Figure 5.2. Histograms of OEF and CMRO2 maps of a healthy subject reconstructed with 
and without constraints. Physiologically improbable OEF values (>1 or <0) were 
eliminated. 
 
Compared to baseline, CGM susceptibility increased by 3.8 ± 1.11 ppb (p<0.01), 
4.38 ± 1.71 ppb (p<0.01), 4.96 ± 1.25 ppb (p<0.01), and CBF decreased by 16.3 ± 7.0 
ml/100g/min (p<0.01), 18.8 ± 5.3 ml/100g/min (p<0.01), and 18.5 ± 4.4 ml/100g/min 
(p<0.01), for caffeine, first and second hyperventilation experiments, respectively. This 
corresponded to a baseline CMRO2 of 149 ± 16 µmol/100g/min, 153 ± 19 µmol/100g/min, 
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and 150 ± 20 µmol/100g/min with an OEF increase from 33.6 ± 3.4% to 39.9 ± 4.8% 
(p<0.01), 32.3 ± 3.3% to 43.6 ± 6.2% (p<0.01), and 34.1 ± 3.8% to 42.8 ± 6.8% (p<0.01) 
in CGM. VT and WM ROI measurements of CMRO2 and OEF are listed in Table 5.1.  
Figure 5.3 shows CMRO2 maps in one healthy volunteer across the brain obtained 
from caffeine, HV1 and HV2 experiments, as well as its corresponding T1 BRAVO images. 
The CMRO2 maps show good consistency across different scans and good gray-white 
matter contrast in reasonable agreement with anatomical images.  
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 Figure 5.3. An example of volumetric CMRO2 maps of a healthy subject generated from 
the caffeine and HV1 and HV2 scans using the proposed method with constraints. The 
corresponding T1 BRAVO images are shown on the right. The CMRO2 maps show good 
consistency across scans and have a similar degree of good gray-white matter contrast as 
the anatomical T1 BRAVO images. 
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Figure 5.4 shows baseline and challenged OEF, CMRO2, 𝜒𝜒𝑛𝑛𝑏𝑏 maps and T1 BRAVO 
images from the 3 different experiments.  OEF maps also demonstrate good consistency 
among experiments. Global increase in OEF after vaso-constrictive challenge can be 
appreciated. In contrast to CMRO2 maps, OEF maps lose some of the gray-white matter 
contrast and have smoother appearance. 
 
 
Figure 5.4. An example of OEF, CMRO2, and 𝜒𝜒𝑛𝑛𝑏𝑏  maps in a second subject. The 
corresponding T1 BRAVO images are shown on the right. 
 
Figure 5.5 showed Bland-Altman plots comparing VT ROI measurements of 
CMRO2 and OEF maps between different experiments. All six comparisons show good 
agreements. OEFchal between caffeine and HV1 experiments show a difference of 3.4% 
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(p<0.05). Small bias (<4% of the average of the two measurements) are detected in other 
comparisons without statistical significance (p>0.05). 
 
Figure 5.5. Bland-Altman plots comparing CMRO2 and OEF maps between HV1 and 
caffeine scans, and between HV1 and HV2 scans. Plot e show 3.4% bias in OEF (P<0.05). 
Other plots shows small bias (<4% of the average of the two measurements) with no 
statistical significance (P>0.05). 
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Table 5.2. CMRO2 measurements in gray matter reported in previous studies. 
 
 
CMRO2 (μmol/100g/min) Reference 
155 ± 39 Bulte et. al., NeuroImage 2012 (7) 
145 ± 30 Gauthier  et. al., NeuroImage 2012 (8) 
184 ± 45 Wise et. al., NeuroImage 2013 (9) 
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5.6    DISCUSSION 
 
Our preliminary results in young healthy subjects demonstrate the feasibility of fast 
QSM-based CMRO2 mapping using hyperventilation. Advantages of hyperventilation over 
other vascular challenges such as caffeine (52), acetazolamide, or hyperoxia (7-9) include 
simple setup, rapid vascular response, and an excellent safety profile, although it might 
require subject coaching prior to scanning and can induce minor discomfort. Compared to 
caffeine challenge, hyperventilation shortened the total time of the CMRO2 mapping 
protocol from an average of 67 min (including a 30 minute waiting time) to 15 min and 
provided images that are visually comparable, although no direct quantitative comparison 
was performed in this study. Hyperventilation demonstrated good reproducibility in 
combination with ease of implementation, suggesting that CMRO2 mapping based on 
QSM and hyperventilation may be an effective tool in the study and management of 
cerebrovascular diseases such as acute ischemic stroke or chronic hypoperfusion. 
In this study, we used hyperventilation to induce vasoconstriction. Voluntary 
hyperventilation in our healthy subjects was found to produce an average of 31% reduction 
in CBF on average in CGM, which was slightly more effective than caffeine (27% 
reduction) and similar to previously reported values (29,30). For sick patients with 
difficulty to perform voluntary hyperventilation, the widely available ventilator can be used. 
While hyperventilation induced vasoconstriction varies with patients, such variation does 
not affect CMRO2 mapping as long as sufficient vasoconstriction is induced. The CMRO2 
values measured in CGM using hyperventilation in this study were found to agree well 
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with those obtained in prior studies using caffeine challenge (27). These values were also 
similar to those reported in the existing MRI literature (7-9) (Table 5.2).  
The QSM-based CMRO2 technique described here may provide several unique 
advantages over previous CMRO2 mapping approaches. One of the major challenges in 
“calibrated fMRI” is the calibration procedure and modeling, which was required in the 
R2* modeling for [dHb] (53,54). QSM solves the field-to-susceptibility source inverse 
problem based on Maxwell’s equation using the phase of the GRE data. Magnetic 
susceptibility measured on QSM is a physical quantity that is independent of imaging 
parameters and has a well-defined quantitative linear relationship with blood oxygenation 
(16,17,27). Therefore, calibration between relaxation rates (R2 and R2*) and blood 
oxygenation (53) is not needed for the well-defined quantitative relationship between 
susceptibility and blood oxygenation. Gas manipulation equipment to resolve multiple 
empirical parameters in calibrated fMRI approaches is not needed for QSM based approach. 
By separating susceptibility contribution of blood and tissue, QSM-based CMRO2 
technique also produces χnb maps (Fig. 5.4), which may be used for measuring the 
susceptibility in tissues (e.g. iron or myelin) when the blood contribution cannot be 
neglected. Additionally, QSM reduces blooming artifacts inherent in R2* and R2’ by 
deconvolving the field. Finally, there are additional practical advantages to the 
hyperventilation challenge. Hypercapnia/hyperoxia gas manipulation is not as easily 
implemented as hyperventilation. Though acetazolamide vascular challenge is generally 
well-tolerated, it is contraindicated in certain groups of patients and may produce adverse 
side effects.  
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In CMRO2 and OEF mapping, noise in MRI data leads to spatially fluctuating errors 
and extreme values because of the poor condition of the system matrix (Eq. 5.6 and Fig. 
5.1). Oxygen consumption induced MRI signal changes in brain tissue are invariably small. 
Accordingly, it is important to use prior knowledge to improve the system matrix condition, 
or more precisely to find a maximum a posteriori estimate in the Bayesian statistical 
framework (Eq. 5.7). In this work, we used the prior knowledge that 1) OEF should be 
within [0,1], 2) the global CMRO2 estimated from the map should equal that estimated 
from the draining veins, and 3) the search for the maximal posterior probability (Eq. 5.7) 
should start reasonably (precondition). Compared to our prior result, this constrained 
preconditioned search has resulted in much improved SNR in CMRO2 and OEF (Fig. 5.1). 
In this study, global OEFs were estimated from the straight sinus and global CBFs 
were estimated by taking the sum of all voxels in CBF maps covering the whole brain. Our 
measurements, 𝐶𝐶𝑂𝑂𝐶𝐶𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡𝑣𝑣 = 26.5 ± 3.1%  and  𝐶𝐶𝐶𝐶𝐶𝐶𝑚𝑚𝑡𝑡𝑎𝑎𝑛𝑛_𝑏𝑏𝑎𝑎𝑡𝑡𝑡𝑡 = 51.6 ± 5.8𝑚𝑚𝑚𝑚/100𝑑𝑑/𝑚𝑚𝑖𝑖𝑚𝑚 
agree well with global OEF and global CBF estimated from GRE phase and phase contrast 
in the superior sagittal sinus reported in previous studies (55,56). Recent studies showed 
that blood flow challenges such as hyper-, hypoxia, and hyper-, hypocapnia, can change 
global CMRO2 by 5 to 20% (57-61). Here we observed a small change of -4.31 ± 11.4%, 
-3.43 ± 11.0%, and -3.69 ± 11.73% following caffeine, HV1 and HV2 challenges, 
respectively, in global CMRO2 as measured in the straight sinus (p>0.05). These values 
were not statistically different in our cohort. Nevertheless, we assumed that the local 
CMRO2 in each brain voxel changes by the same relative amount as the global CMRO2 in 
the reconstruction. The spatial and temporal variation of CMRO2 during hyperventilation 
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can be a source of error and warrants further investigation. In the cases of acute infarction 
or active bleeding, blood might leave the vasculature and pool inside tissue. This 
phenomenon might need to be considered in the mass conservation for accurate estimation 
of global CMRO2 from large draining veins. In future studies, an additional phase contrast 
acquisition can be used for a more direct measurement of blood flow in the straight sinus 
to obtain global CBF (55,56). 
One of the limitations in our study is the relatively short (30 seconds) HV time 
before the HV ASL scan. In order to estimate the onset of the CBF steady state, we 
performed additional scans in two volunteers from this study. With our 3D ASL sequence 
we were able to obtain a low-resolution whole brain CBF map every 50 seconds. After 
baseline scans, the subjects were asked to start hyperventilating as in the study while ASL 
scans acquired simultaneously for a total of 250 seconds. The data showed that steady state 
was reached by the second scan and remained there until the end of 
scanning/hyperventilation, with the first scan showing a CBF that was approximately 35% 
higher than the steady-state value.  The 3D ASL sequence used in this study is a stack-of-
spirals acquisition that repeatedly returns to the center of k-space throughout the 
acquisition. Considering the scan time of 3 minutes as used in this study, approximately 
85% of HV CBF data was acquired during the steady state, while QSM was acquired well 
after the steady state was reached. Hence the assumption of a steady state brain condition 
is valid. 
The lack of Hct measurements is another limitation of this preliminary feasibility 
study. We assumed Hct𝑡𝑡𝑡𝑡 = 0.47 and calculated Hct𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 as 0.759Hct𝑡𝑡𝑡𝑡 as measured in 
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(31). We have quantified the maximum CMRO2 estimation error caused by inter-subject 
variability of Hct𝑡𝑡𝑡𝑡 by repeating the calculations for both the lower (0.38) and upper bound 
(0.52) of the expected human Hctss range. For the cortical GM, the maximum difference 
between the CMRO2 value for Hct=0.47 and the two CMRO2 values obtained in this 
manner was 2.4 ± 1.1% (n=11). The ratio between Hct𝑡𝑡𝑡𝑡 and Hct𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 may vary spatially 
and among subjects. The potential error due to such variation warrants further investigation.   
In this work HV scans had lower resolution compared to caffeine scans. The 
tradeoffs in CMRO2 and OEF maps due to the reduced spatial resolution are partial volume 
error in CBF and QSM maps which can propagate into CMRO2 and OEF images. However, 
in this study we did not perform an explicit direct comparison between different spatial 
resolutions in the same subject. Further studies are warranted to investigate the partial 
volume error in the proposed method. 
Our OEF was slightly lower (2.5%) in WM than in CGM in all three experiments. 
This observed discrepancy may be attributed to the lower CBF changes detected in WM 
than the changes in CGM after caffeine and HV challenges (-6.0±4.3ml/100g/min vs -
17.9±5.53ml/100g/min, p<0.01). The small absolute CBF change and the known 
challenges of accurately quantifying CBF in WM with ASL MRI perfusion make OEFs in 
these regions more difficult to resolve. Our protocol was based on a routine clinical 
protocol used at our institution. By modifying the protocol according to the recent white 
paper by Alsop et al (62), SNR could potentially be improved at a cost of scan time increase. 
This discrepancy may also be attributed to the challenges associated with accurately 
mapping CBV in white matter. For this feasibility study, CBV was estimated from CBF 
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using an empirical relationship derived from normative PET data and the Grubb’s exponent 
of 0.38, which can be a source of error.  This limitation may be addressed by direct 
measurements of CBV using technique such as dynamic study with contrast agent (63,64), 
or by non-contrast MRI with detailed vascular signal modeling such as Vascular Space 
Occupancy (VASO)(65-67),  fMRI with multiple inversion times (68), or quantitative 
BOLD (69,70). CBVv / CBVtotal was assumed to be 77% at baseline (32). We also 
processed the data with a CBVv / CBVtotal of 50% as assumed in a previous study (27) and 
found a relatively small difference of 1.0 ± 1.4% in CMRO2 for cortical GM across subjects.  
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5.7    CONCLUSION 
 
Hyperventilation is a feasible, reproducible and efficient vasoconstrictive challenge 
for QSM based quantitative CMRO2 mapping in healthy subjects with good reproducibility 
and offers 4-fold protocol time reduction compared to using caffeine as a challenge. 
Constrained optimization within physical range of OEF provides substantial reduction of 
noise errors in CMRO2 and OEF maps. The applicability of this protocol for a general 
patient population remains to be investigated. 
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5.8    APPENDIX  
 
Calculation of heme ([𝑑𝑑]) in tissue blood micro-vascularture. [𝑑𝑑] = 4𝑑𝑑𝐻𝐻𝐻𝐻𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡  𝜌𝜌𝑅𝑅𝑅𝑅𝑅𝑅,𝑑𝑑𝑏𝑏𝐶𝐶𝑑𝑑𝑏𝑏 = 7.53 µmol/ml  
where 𝑑𝑑𝐻𝐻𝐻𝐻𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 = 0.357, 𝜌𝜌𝑅𝑅𝑅𝑅𝑅𝑅,𝑑𝑑𝑏𝑏 = 0.34𝑑𝑑/𝑚𝑚𝑚𝑚 is mass concentration of Hb in a red blood 
cell (71),  𝐶𝐶𝑑𝑑𝑏𝑏 = 64450 × 10−6 𝑑𝑑/µ𝑚𝑚𝑚𝑚𝑚𝑚 is the the molar mass of dHb (72), 4 account of 
4 heme per Hb molecule. 
Calculation of Volume Fraction of Hb in RBC δHb   
 
δHb  is estimated from Hb mass concentration in a red blood cell ( 𝜌𝜌𝑅𝑅𝑅𝑅𝑅𝑅,𝑑𝑑𝑏𝑏 =0.34𝑑𝑑/𝑚𝑚𝑚𝑚)(71), and Hb density in pure aggregate (𝜌𝜌𝑑𝑑𝑏𝑏 = 1.335 𝑑𝑑/𝑚𝑚𝑚𝑚)(73) 
δHb =  𝜌𝜌𝑅𝑅𝑅𝑅𝑅𝑅,𝑑𝑑𝑏𝑏𝜌𝜌𝑑𝑑𝑏𝑏 = 0.255 
Calculation of Volume Susceptibility of Oxyhemoglobin XoHb  and DeoxyHemoglobin XdHb  
 
The volume susceptibility of Oxyhemoglobin XoHb relative to water is estimated from the 
reported mass susceptibility of globin relative to vacuum (−0.587 × 10−6 𝑚𝑚𝑚𝑚 𝑑𝑑⁄ ) (CGS 
unit) (73,74), and Hb density in pure aggregate (𝜌𝜌𝑑𝑑𝑏𝑏 = 1.335 𝑑𝑑/𝑚𝑚𝑚𝑚) (73). XoHb =  −4𝜋𝜋𝜌𝜌𝑑𝑑𝑏𝑏(0.587 × 10−6 𝑚𝑚𝑚𝑚 𝑑𝑑⁄ ) − (−9035 𝑝𝑝𝑝𝑝𝑏𝑏) =  −813𝑝𝑝𝑝𝑝𝑏𝑏 
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where 4𝜋𝜋 is for unit conversion from cgs to si, −9035 𝑝𝑝𝑝𝑝𝑏𝑏 is water volume susceptibility 
relative to vacuum (75). 
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Chapter 6 
 
 
 
 
QSM-based CMRO2 Mapping Without Vaso-Challenge: a Minimal 
Local Variance (MLV) Approach  
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6.1    ABSTRACT 
Purpose 
The objective of this study was to demonstrate the feasibility of a cerebral metabolic 
rate of oxygen (CMRO2) mapping method based on its Minimum Local Variance (MLV) 
without vascular challenge using quantitative susceptibility mapping (QSM) and cerebral 
blood flow (CBF). 
Methods 
3D multi-echo gradient echo imaging and arterial spin labeling (ASL) were 
performed in 11 healthy subjects to calculate QSM and CBF. MLV was used to compute 
whole brain CMRO2 map from QSM and CBF. The MLV method was compared with a 
reference method using caffeine challenge. Their agreement within the cortical gray matter 
(CGM) was assessed on CMRO2, and also on oxygen extraction fraction (OEF) maps at 
both baseline and challenge states.  
Results 
Mean CMRO2 (in µmol/100g/min) obtained in CGM using caffeine challenge and 
MLV were 142 ± 16.5, and 139 ± 14.8 µmol/100g/min respectively; corresponding 
baseline OEF were 33.0 ± 4.0%, and 31.8 ± 3.2%, respectively. MLV and caffeine 
challenge methods showed no statistically significant differences across subjects with 
small (<4%) biases in CMRO2 and OEF values.  
Conclusion 
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MLV-based CMRO2 mapping without vascular challenge using QSM and ASL is 
feasible in healthy subjects. 
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6.2    INTRODUCTION 
Oxygen is critical for aerobic energy metabolism in cerebral tissue to sustain normal 
neural function. Non-invasively and quantitatively mapping cerebral metabolic rate of 
oxygen (CMRO2) can provide valuable information on tissue viability and activity in both 
research and clinical settings (1). CMRO2 is the product of cerebral blood flow (CBF) and 
oxygen extraction fraction (OEF). CBF can be mapped using arterial spin labeling (ASL), 
but OEF requires determination of deoxyheme (dH) in the draining veins/venules for each 
voxel of tissue. Several MRI techniques have been proposed to map dH: 1) Quantitative 
imaging of extraction of oxygen and tissue consumption (QUIXOTIC), which uses a 
velocity-selective spin labeling to selectively map venous blood T2 and oxygenation (2). 
2) Calibrated fMRI, which models the magnitude R2* decay of the blood oxygen level 
dependent (BOLD) signal as a complex function of dH concentration ([dH]), typically 
estimating [dH] from signal measurements at two vascular challenges such as hyperoxia 
and hypercapnia to obtain CMRO2 (3-5). 3) quantitative BOLD, which uses a specific 
venous geometry of randomly oriented tubes to model [dH] dependence of signal generated 
in asymmetric spin echo (6,7) or 3D multi-echo gradient echo data (8). One limitation of 
these approaches is that only the signal magnitude is utilized for estimating [dH]. 
Signal phase can be utilized through quantitative susceptibility mapping (QSM) 
processing to generate tissue magnetic susceptibility (9,10). Unlike R2 and R2*, the 
relationship between [dH] and tissue susceptibility is linear in its concentration and 
independent of imaging parameters (11-13). Hence, QSM can be used to quantify 
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oxygenation in large veins (14-18) and in tissue (19,20). [dH] in tissue can be determined 
from QSM by compensating for contribution from non-heme iron such as those stored in 
ferritin. A single vascular challenge to modify blood flow, either vasoconstrictive or 
vasodilative, has been used to separate the susceptibility contribution from blood and non-
blood tissue (19,20). However, even the requirement of a single challenge may limit its 
practical utility. 
In this study, a new algorithm called the minimal local variance (MLV) is proposed 
to obtain CMRO2 maps without blood flow challenge. MLV assumes the constant CMRO2 
and non-blood tissue susceptibility (χnb) within each tissue type (gray and white matter) 
across small regions of the brain. This allows overcoming the ill-posedness of the 
optimization problem. The results in healthy subjects are compared to those obtained using 
a caffeine-challenge.  
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6.3    OVERCOMING ILL-POSED INVERSION USING MLV 
 
6.3.1 CMRO2 and OEF Reconstruction 
According to mass conservation of oxygen molecules, the cerebral metabolic rate 
of oxygen CMRO2 (µmol/100g/min) can be expressed as  
CMRO2 = CBF ∙ ([dH]v − [dH]a)                                           [6.1] 
where CBF is the cerebral blood flow (ml/100g/min ) and [dH]v  and [dH]a  are the 
deoxyheme molar concentration (µmol/ml) in venous and arterial blood, respectively. 
Oxygen Extraction Fraction (OEF) is the percentage of oxygen extracted from 
arterial blood and can be expressed as  
OEF = [dH]v−[dH]a[H]−[dH]a                                                   [6.2] 
where [H] = 7.53 µmol/ml is the heme molar concentration in tissue blood assuming a 
tissue blood hematocrit of Hcttissue = 0.357 , which is estimated from an assumed 
hematocrit of Hct𝑠𝑠𝑠𝑠 = 0.47 in the straight sinus and a Hct ratio of 0.759 between large 
vessel and brain tissue (21).  [dH]a = 0.15 µmol/ml assuming 98% arterial oxygenation 
(see Appendix). 
[𝑑𝑑𝑑𝑑]𝑣𝑣 in Eq. 6.1 and 6.2, and subsequently CMRO2 can be mapped using QSM 
(19,20). 
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CMRO2 = CBF � χ−χnb −χ0 CBVv∙XdH,mol − [dH]a�                                       [6.3] 
Here, χ is the magnetic susceptibility mapped using QSM. χ0  reflects the susceptibility 
contributions from pure oxygenated blood and arterial deoxyhemoglobin (see Appendix). CBVv is the venous blood volume fraction, estimated as 77% of total CBV (22). XdH,mol = 151.054 ppb 𝑚𝑚𝑚𝑚 𝜇𝜇𝑚𝑚𝜇𝜇𝑚𝑚⁄  is the molar magnetic susceptibility of dH (11,12).  
In Eq. 6.3, CMRO2 and χnb  are the two unknowns. In previous studies, 
susceptibility and blood flow of baseline and challenged brain states were mapped (19,20). 
Hence, CMRO2, χnb , and subsequently OEF can be solved. However, CBF challenges 
such as caffeine administration are time-consuming, presenting difficulties when 
performing in patients.  
To solve this limitation, the QSM and CBF maps were segmented into small blocks 
and each block was further segmented into two tissue types (gray and white matter) using 
T1 weighted images. Within each block and each tissue type, χnb and CMRO2 are assumed 
to be constant. This assumes that, within a small local region, the same tissue type has 
similar biological and chemical makeup. Hence, CMRO2 and χnb of each block and tissue 
type can be organized into into a vector of unknowns 𝑥𝑥 in a linear system format: 
�
ψ1 1
ψ2 1
⋮
ψN
⋮1������
A
�
CMRO2
χnb
�
�����
x
= �ϕ1ϕ2⋮
ϕN
�
�
b
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Here ψi = CBVv,i ∙ XdH,mol/CBFi  and  ϕi = χi − CBVi ∙ �Χba + XdH,mol ∙ [dH]a� . The 
index i = 1, … , N denotes the iPth voxel of a given tissue type with a block with 𝑁𝑁 the total 
number of such voxels in that block. Χba = −108.3 ppb  is the susceptibility of fully 
oxygenated blood (See Appendix).  
In the following, this algorithm will be referred to as minimum local variance 
(MLV). To reduce error propagation and improve convergence speed, a right 
preconditioning technique is applied (23). The new system is defined as APxP = b, where AP = AP  and xP = P−1x .  P  is the preconditioner defined as P =
diag�CMRO2,ub , avg(χ)� which is designed to allow the elements of xP to have similar 
order of magnitude. CMRO2,ub is the upper bound of CMRO2 calculated within each block 
using Eqs.1&2 using OEF = 1. avg(χ) denotes the average of susceptibility of voxels 
within a block that are of the same tissue type. 
The solution for a given tissue type (grey or white matter) was obtained by 
minimizing the following cost function over the whole brain using a limited-memory 
Broyden–Fletcher–Goldfarb–Shanno-Bound (L-BFGS-B) algorithm (24,25) with 
physiological bounds on CMRO2: 
𝐱𝐱 = argmin
𝐱𝐱
�‖𝐀𝐀𝐱𝐱 − 𝐛𝐛‖2
2 + λ�CMRO2global − 𝐂𝐂𝐂𝐂𝐂𝐂𝐂𝐂𝟐𝟐�����������2� 
with 𝟎𝟎 ≤ 𝐂𝐂𝐂𝐂𝐂𝐂𝐂𝐂𝟐𝟐 ≤ 𝐂𝐂𝐂𝐂𝐂𝐂𝐂𝐂𝟐𝟐,𝐮𝐮𝐛𝐛      [6.4] 
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𝐀𝐀 is diag(AP), a block-wise diagonal matrix with the matrix AP for the given tissue type 
and for each block along the diagonal, and 𝐱𝐱, 𝐛𝐛, and 𝐂𝐂𝐂𝐂𝐂𝐂𝐂𝐂𝟐𝟐 are the concatenated column 
vectors of xP, b, and CMRO2  for that same tissue type and for each block, respectively. In 
the second term, 𝐂𝐂𝐂𝐂𝐂𝐂𝐂𝐂𝟐𝟐���������� is the average CMRO2 across all blocks for the given tissue type. 
This term imposes a global physiological constraint based on mass conservation: the global 
CMRO2 estimated from the CMRO2 map should be similar to that estimated from straight 
sinus. Here, CMRO2global  is estimated from Eq. 6.3. Global cerebral blood flow was 
estimated by averaging CBF over all brain voxels. The magnetic susceptibility of venous 
blood in the straight sinus (SS) was measured in ROIs drawn by a neuroradiologist with 10 
years’ experience (A.G.) and taking CBV = CBVv = 100% , χnb = 0  and Hctss = 0.47 
since only venous blood was present in these ROIs. 𝜆𝜆  is the regularization weighting 
parameter on the global constraint, chosen based on the average value obtained by L-curve 
analysis in three randomly selected subjects (26). 
Whole brain grey matter (GM), white matter (WM), and CSF masks were created 
using the FSL FAST algorithm (27) on the inversion prepared SPGR T1w images. These 
masks were further divided into 6 x 6 x 6 mm3 isotropic blocks. This block based 
computation was performed for the GM and WM separately, selecting within each block 
only those pixels that belong to the corresponding tissue type. This allowed a proper 
convergence when solving Eq. 6.5.To minimize potential bias due to specific block grids, 
blocks were shifted in (3D) diagonal directions 4 times with a step size of 1.5 mm. The 
data were reprocessed and the results were averaged to obtain the final images. 
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CMRO2, OEF, and χnb were also solved using the method described in Zhang et. 
al., 2016 (20). Briefly, assuming χnb  remained the same before and after challenge, 
susceptibility and CBF measurements of each voxel in baseline and challenged states were 
paired to solve OEF and χnb  for every voxels using LBFGS-B solver with identical 
OEF/CMRO2 bounds and global CMRO2 constraint as the proposed method. The 
percentage change of CMRO2 between the two states were estimated in the straight sinus 
and incorporated into the minimization. 
For this feasibility study, CBV was estimated from CBF based on a linear regression 
derived from CBF and CBV measurements in gray and white matter using 15O Positron 
Emission Tomography (PET) in healthy subjects (n=34) (28): CBV = (0.0723 CBF +1.144)/100. Post caffeine CBV was estimated from baseline CBV using the Grubb’s 
exponent of 0.38 (29) because the empirical CBF and CBV relationship derived from PET 
data was from healthy subjects without vaso-challenges and may not be suitable for 
estimating post caffeine CBV. CBV changes after challenge were assumed to be on arterial 
side as suggested in the literature (30). 
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6.4    EXPERIMENTS AND ANALYSIS 
 
6.4.1 Data Acquisition 
 
The study was approved by the local Institutional Review Board. Healthy volunteers 
were recruited (n=11, 1 female, mean age 34 ± 12 years) for brain MRI on a 3T scanner 
(HDxt, GE Healthcare) using an 8-channel brain receive coil. All subjects were instructed 
to avoid caffeine or alcohol intake 24 hours prior to MRI.  
MRI was performed before and 25 min after the oral administration of 200 mg 
caffeine. The protocol consisted of a 3D fast spin echo (FSE) arterial spin labeling (ASL) 
sequence, a 3D multi-echo spoiled gradient echo (SPGR) sequence, and an inversion 
prepared T1w SPGR sequence (BRAVO). 
The 3D FSE ASL sequence parameters were: 20 cm FOV, 3 mm isotropic resolution, 
1500 ms labeling period, 1525 ms post-label delay, 62.5 kHz readout bandwidth, spiral 
sampling of 8 interleaves with 512 readout points per leaf, 35 axial slices, 10.5 ms TE, 
4796 ms TR, 3 signal averages, and 6 min scan time. 
The 3D SPGR sequence parameters included: 0.52 mm in-plane resolution, 2 mm 
slice thickness, identical volume coverage as the 3D FSE ASL sequence, 7 equally spaced 
echoes, TE1 = 4.3 ms, echo spacing 7.9 ms, TR 56.6 ms, 62.5 kHz readout bandwidth, 15o 
flip angle, and 7 min scan time. The pulse sequence was flow-compensated in all three 
directions (18).  
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The inversion prepared SPGR T1w sequence parameters were: 1.2 mm isotropic 
resolution, identical volume coverage as the 3D FSE ASL sequence, TE 2.92 ms, TR 7.68 
ms, prep time 450 ms, ±19.5 kHz readout bandwidth, 15o flip angle, and 2 min scan time. 
 
6.4.2 CBF and QSM Reconstruction 
 CBF maps (ml/100g/min) were generated from the ASL data using the FuncTool 
software package (GE Healthcare, Waukesha, WI, USA). For QSM reconstruction, an 
adaptive quadratic-fit of the GRE phase (18) followed by a projection onto dipole fields 
(31) was used to obtain the local field map. Susceptibility was computed from the local 
field map using the Morphology Enabled Dipole Inversion (MEDI) algorithm (32-34). 
Susceptibility values were referenced to the susceptibility of water, as estimated in the 
cerebrospinal fluid (CSF) masks (see below). All images were co-registered and 
interpolated to the resolution of the QSM maps using the FSL FLIRT algorithm (35,36). 
 
6.4.3 Statistical Analysis 
 
Cortical grey matter (CGM) was segmented into the bilateral anterior (ACA), 
middle (MCA) and posterior cerebral artery (PCA) vascular territories (VT) by the same 
neuroradiologist (A.G.). For each ROI, the mean and standard deviation of CMRO2 and 
OEF values were measured. Bland-Altman plots and paired sample t-tests were performed 
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to compare CMRO2 and OEF values in the VTs using previous and proposed methods. P 
values lower than 0.05 were considered to indicate statistical significance. All data were 
expressed as mean ± standard deviation. 
 
6.4.4 Numerical Simulation 
Numerical simulation was performed to investigate CMRO2 estimation error caused 
by 1) CBF error, 2) partial volume effect, and 3) QSM error. One block with matrix size 
of 8×8×5, the same block size in this study, was constructed. The upper and lower half was 
set to be white (WM) and gray matter (GM), respectively. Inputs were CMRO2, χnb, and 
CBF (ground truth): CMRO2 of GM: 181, CMRO2 of WM: 138 (μmol/100g/min), χnb of 
GM: 0.02, χnb of WM: 0.45 WM (ppb). CBF values are given voxel-wise with normally 
randomized values, 49.5 ± 4.3 for WM and 64.8 ± 3.6 for GM (ml/100g/min). These values 
were the average values in a subject and, for the CBF standard deviation, the whole GM 
and WM standard deviation was calculated and divided by five to obtain a reasonable 
estimation for the same tissue type in small brain region. The QSM was subsequently 
estimated voxel-wise with the given CMRO2, χnb, and CBF values. 1) To investigate the 
CBF error propagation in CMRO2 map, we considered two cases; 1-1) low SNR CBF and 
1-2) biased CBF. For low SNR case, noise was added to CBF (SNR: 4.5), and MLV was 
performed subsequently. This was repeated 100 times to obtain average and standard 
deviation. CBF SNR was estimated the ratio of mean over standard deviation in the caudate 
nucleus, 4.5±1.7 (n=5). 2) To investigate the partial volume effect within individual voxels, 
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the QSM and CBF value at the GM boundary layer was averaged with an immediate 
neighboring WM QSM and CBF value, respectively. This means that GM boundary voxel 
actually consisted of half GM and the other half WM, but was treated as GM. 3) To estimate 
QSM error propagation into CMRO2 estimation, noise was added to QSM (SNR 3.1, 
estimated in the same way as CBF SNR). This was repeated 100 to obtain average and 
standard deviation. For all cases, global CMRO2 constraint weighting (λ) was set to be 500 
as used in this study.   
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6.5    RESULTS 
Figure 6.1 shows the averaged L-curves of the three randomly selected subjects 
using MLV method. 𝜆𝜆 (Eq. 6.4) was chosen to be 500. In CGM, CBF decreased by 16.3 ± 
7.0 ml/100g/min (p<0.01) after the caffeine challenge. CMRO2 in CGM was 142 ± 16.5, 
and 139 ± 14.8 µmol/100g/min for the caffeine challenge based method and the MLV based 
method, respectively. These corresponded to OEFbase of 33.0 ± 4.0%, and 31.8 ± 3.2%, and 
to OEFchal of 39.0 ± 4.9%, and 39.3 ± 4.1%, respectively. VT and WM ROI measurements 
of CMRO2 and OEF are listed in Table 6.1.  
Figure 6.2 shows CMRO2 maps reconstructed using the caffeine challenge based 
and the MLV based methods across the brain in one healthy volunteer, next to the 
corresponding inversion prepared SPGR T1w images for anatomical reference. CMRO2 
maps show good consistency and the gray-white matter contrasts are in reasonable 
agreement with anatomical images. 
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 Figure 6.1. The figure shows the averaged L-curves of the three randomly selected subjects 
using MLV method. λ (Eq. 6.4) was chosen to be 500. 
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 Figure 6.2. An example of 3D CMRO2 map in axial, sagittal and coronal section from a 
healthy subject using caffeine challenge and MLV methods. The corresponding inversion 
prepared SPGR T1w images are shown on the right. CMRO2 maps of both methods show 
good consistency and have good gray-white matter contrast in agreement with the inversion 
prepared SPGR T1w images.  
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Figure 6.3 shows OEFbase, OEFchal, and baseline CMRO2 maps of a second subject 
reconstructed with the caffeine challenge and MLV methods.  OEF maps also demonstrate 
good consistency between the different reconstruction methods. A global increase in OEF 
coinciding with the caffeine-induced global CBF decrease can be readily appreciated.   
Figure 6.4 shows the Bland-Altman plots comparing CMRO2 and OEF values in 
VT between the caffeine challenge based and the MLV based method. These comparisons 
show <4% difference of the average of the two measurements without statistical 
significance (p>0.05). 
Numerical simulation showed that CMRO2 estimation error was affected by low 
SNR CBF and by biased CBF. In the case of low SNR CBF (SNR 4.5), CMRO2 error was 
6.0% for GM and 4.4% for WM. In the case of biased CBF (10% underestimation), relative 
CMRO2 error for both GM and WM was 10%. In terms of the partial volume effect at the 
GM boundary, the relative CMRO2 difference was 3.0 % for GM and 2.2 ×10-5 % for WM. 
In case of the QSM noise propagation into CMRO2 (SNR 3.1), the resultant CMRO2 error 
was 0.1 % for WM 1.5 % for GM. 
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Figure 6.3. An example of OEF and CMRO2 maps in a second subject reconstructed using 
the challenge based (left) and MLV based (right) method.   
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Figure 6.4. Bland-Altman plots comparing CMRO2 and OEF maps reconstructed using 
the challenge based and the MLV based method. Small bias (<4% of the average of the 
two measurements) are detected in all comparisons without statistical significance (p>0.05). 
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Table 6.1. CMRO2 (µmol/100g/min) and OEF (%) pre and post challenge measurements 
within VT and WM ROIs reconstructed using challenge and MLV methods across subjects 
(mean ± std). 
 CMRO2 OEFbase OEFchal 
 Challenge MLV Challenge MLV Challenge MLV 
ACA 138.7 ± 15.4 137.1 ± 18.7 31.4 ± 5.0 30.3 ± 4.1 36.5 ± 4.9 37.8 ± 5.5 
MCA 142.5 ± 20.4 136.9 ± 17.3 34.1 ± 4.4 32.4 ± 3.4 40.7 ± 5.7 40.2 ± 4.6 
PCA 144.7 ± 28.3 147.5 ± 28.7 31.6 ± 4.5 31.8 ± 4.8 37.4 ± 5.0 38.5 ± 5.6 
WM 107.3 ± 16.5 106.2 ± 13.5 31.3 ± 4.1 31.6 ± 3.8 36.5 ± 5.6 35.0 ± 4.2  
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6.6    DISCUSSION 
Our preliminary results demonstrate the feasibility of a noninvasive CMRO2 
mapping without a vascular challenge based on QSM and CBF using MLV. The CMRO2 
measurements agrees well between the challenge and MLV methods in healthy subjects. 
The elimination of the vascular challenge greatly reduces the complexity of the scanning 
protocol, the overall exam time and the potential risks associated with the administration 
of agents that modify blood flow.  
Previously reported R2*-based CMRO2 mapping (3-5) methods are limited by R2* 
modeling for [dH]. Calibration of the model parameter is required, which may vary with 
scanning parameters such as field strength. Consequently, measurements at three brain 
states (normoxia, hypercapnia, and hyperoxia) are needed for quantitative CMRO2 
mapping. However, it is very cumbersome to administer stimulants to the brain to generate 
three distinct states. Magnetic susceptibility has a completely defined linear relation with 
[dH], eliminating the R2* model parameter calibration and reducing the number of required 
brain states for CMRO2 mapping to two. The two brain states are needed to separate the 
susceptibility contribution from blood and non-blood tissue and can be achieved using 
vascular challenges, such as by administering caffeine (19) or using hyperventilation (20). 
However, even administering a single challenge can be cumbersome in practice. Using 
MLV quantitative CMRO2 map can be obtained without such a challenge, making CMRO2 
more feasible to perform in practice. 
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The MLV implemented in this study used an isotropic block size of 6x6x6mm3 such 
that multiple CBF voxels, acquired at a 3x3x3mm3 isotropic resolution, were available 
within each block. In 1909, Brodmann divided the human cerebral cortex into 44 areas 
according to its cytoarchitecture (37), which were later shown to be related to various 
neural functions (38,39). In this study, the cerebral cortex was divided into more than 4000 
regions. Hence, the assumptions of constant CMRO2 and 𝜒𝜒𝑛𝑛𝑛𝑛 within the same block and 
tissue type may be considered as reasonable. This MLV implementation then resulted in 
multiple data points to uniquely estimate the two unknowns CMRO2 and 𝜒𝜒𝑛𝑛𝑛𝑛 within each 
block. There is substantial amount of noise propagation from the CBF and QSM input to 
the CMRO2 output, which can be further reduced using a global CMRO2 constraint as the 
regularization in Eq. 6.4. 
There are several limitations in this study. In MLV, χnb and CMRO2 are assumed 
to be constant within each block and each tissue type. Therefore, MLV derived CMRO2 
values are block-wise constant and depend on accurate tissue segmentations. MLV may be 
further improved by considering physiologically relevant brain parcellations. The rationale 
for choosing 6×6×6 mm3 isotropic blocks was that, for this data set, each block contained 
exactly 2×2×2 CBF and 12×12×3 QSM, both deemed large enough to avoid ill-posedness 
but not too large to avoid violating the homogeneous tissue assumptions. The block size 
was chosen to balance between these competing demands. To investigate the effect of 
block size, we applied different block-sizes (2×2×2 mm3and 9×9×9 mm3) for one subject. 
CMRO2 values for cortical GM were 119.0±107.5, 123.5±83.2, and 124.8±64.2 
160 
 
μmol/100g/min for 2mm, 6mm, and 9mm block size respectively. As the block size 
increases, the standard deviation of CMRO2 decreases. Averaging over several sub-block 
shifts, as done in this work, suppresses the resulting piecewise constant appearance. 
Nevertheless, sharp transitions remain between different tissue zones (Fig. 6.2), since 
computations are performed for each tissue type separately. Tissue segmentation can be 
challenging in patients, which might cause error. Further investigation regarding the other 
potential complexities in patients, e.g. difficulties in capturing regional variation within a 
lesion, also needs to be investigated.  Another MLV limitation is the possibility that highly 
deoxygenated vein contribution might be smoothed out with using block based method. If 
some voxels in the same tissue type have strong contribution from highly deoxygenated 
vein, it’s possible that this effect is smoothed out by the other voxels with low vein 
contribution. One possible way to avoid this issue would be to remove the highly 
deoxygenated large veins from gray and white matter mask in the implementation of MLV. 
The lack of Hct measurement is another limitation. We assumed Hctss = 0.47.  We have 
quantified the maximum CMRO2 estimation error caused by inter-subject variability by 
repeating calculations for both the lower (0.38) and upper bound (0.52) of the expected 
human Hct range. For the cortical GM, the maximum CMRO2 difference between Hct = 
0.47 and the two bound cases was 2.45±0.89 (n=11). Another limitation is that QSM-based 
CMRO2 does require CBV measurements as in R2* based methods. Our MLV feasibility 
study here used CBV estimated from CBF assuming an empirical relationship derived from 
normative PET data (28) and assumed a 0.77 ratio between venous and total CBV, as in 
previous R2* and QSM studies (19,20). While both these assumptions are consistent with 
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the literature on healthy subjects (22,30), they may be invalid in some patients. Also, the 
accuracy of CBF measurement by ASL might suffer from low SNR in WM or with large 
veins and long arterial transit times. Our simulation showed that CMRO2 estimation would 
be affected by low SNR CBF (4.4% error in WM with SNR 4.5) and biased CBF values 
(10% error in both WM and GM with 10% underestimation). This may be addressed by a 
direct measurement of CBV using dynamic contrast enhancement (DCE) (40) or a non-
contrast MRI technique such as Vascular Space Occupancy (VASO) (41-43), multiphase 
ASL based CBVa (44) or quantitative BOLD (45). Another limitation of study is the use 
of straight sinus OEF for global CMRO2 constraint. Jugular veins would more ideal to 
estimate the global CMRO2 but are more complicated to images within the same field of 
view and/or coil. Moreover, QSM outside the brain remains challenging due motion and 
the need for additional phase preprocessing such as water-fat separation. Therefore, 
measurements in straight sinus are used under the assumption that straight sinus and jugular 
veins have similar oxygenations, given that OEF has been shown uniform in healthy 
subjects across the brain using 15O PET. Because of the use of flow compensation during 
acquisition and the adaptive quadratic fitting of the field (18) flow effects on QSM are 
minimized. Finally, the subject in this study were young and healthy, and the validation 
and applicability of this technique in a general patient population remains to be investigated. 
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6.7     CONCLUSION 
Our study demonstrated the feasibility of a noninvasive CMRO2 mapping without 
vascular challenge based on QSM and CBF using MLV. In vivo imaging in heathy subjects 
demonstrates that the CMRO2 and OEF maps obtained with the proposed MLV method 
agree well with those obtained using a blood flow challenge based method. 
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6.8    APPENDIX 
 
Calculation of heme concentration ([𝑑𝑑]) in tissue blood [H] = 4Hcttissue  ρRBC,HbMHb = 7.53 µmol/ml  
Where 4 account of 4 heme per Hb, Hcttissue = 0.357 , ρRBC,Hb = 0.34g/ml  is mass 
concentration of Hb in a red blood cell (46),  MHb = 64450 × 10−6 g/µmol is the the 
molar mass of dHb (47). 
Calculation of χo 
χo = CBV ∙ Χba + CBVa ∙ XdH,mol ∙ [dH]a 
Here CBVa = CBV − CBVv = 0.23CBV  is the arterial blood volume fraction.  [dH]a =0.15 µmol/ml is [𝑑𝑑𝑑𝑑] in arterial blood assuming 98% oxygenation. Χba is susceptibility 
of 100% oxygenated blood. 
Χba = HcttissueδHb ∙ XoHb + (1 − HcttissueδHb)Xp = −108.3 ppb 
Where δHb is volume fraction of Hb in RBC. 
δHb =  ρRBC,HbρHb = 0.255 
Here ρRBC,Hb = 0.34g/ml  is Hb mass concentration in a red blood cell (46). ρHb =1.335 g/ml is Hb density in pure aggregate (48). 
XoHb is volume susceptibility of oxyhemoglobin (OHb). 
164 
 
XoHb =  −4πρHb(0.587 × 10−6 ml g⁄ ) − (−9035 ppb) =  −813ppb 
Here 0.587 × 10−6 ml g⁄  is mass susceptibility of globin relative to vacuum in CGS unit 
(48,49). 4𝜋𝜋  is for unit conversion from cgs to si units.  −9035 ppb  is water volume 
susceptibility relative to vacuum (50).   
Xp = −37.7 ppb are the oxyhemoglobin and blood plasma volume susceptibility 
(12). 
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Chapter 7 
 
 
 
 
Conclusions and Recommendations 
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7.1    FUTURE WORK 
 
7.1.1 Investigation of Blood Degradation in Hemorrhagic Patients Using QSM 
 
The study suggests 1) The susceptibility of hematomas are consistently positive 
relative to CSF even during the hyperacute stage, challenging the traditional model that 
hyperacute hematomas contain mostly oxygenated arterial blood which has slightly 
negative susceptibility (1,2); 2) The susceptibilities of hematomas decrease substantially 
from the acute to subacute stage, thus furthering the MRI literature (1,13) about the late 
subacute stage with new insight for a quantitative model to explain the hemoglobin 
degradation process.  
One major improvement is to perform more sophisticated in vitro blood phantom 
experiment. While the phantom experiment demonstrated the course of susceptibility 
changes of degrading blood sample in test tubes, it lacks several important physiological 
processes that might affect the time course and compositions of the hematoma including 
inflammation and hemosiderin formation. Histology and protein analysis should also be 
performed to correlate the susceptibility changes to blood degradation products.  
Another major improvement is to address the uneven sampling density over various 
stages of ICH, especially for the hyperacute stage where only 4 patients were scanned. 
Larger hyperacute ICH patient data are warrant despite the difficulty in execution. 
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The third limitation of this study is its cross-sectional design. Longitudinally serial 
imaging is highly recommended to remove variability among different patients.  
Lastly, histological evidences are recommended to correlate molecular 
compositions to susceptibility changes. This issue can be addressed through follow up 
studies of hematoma susceptibility in animal models or autopsy after patients deceased.  
7.1.2 QSM-based CMRO2 Mapping 
 In chapter 4, a new signal model based on magnetic susceptibility of blood and non-
blood tissue is proposed to overcome some of the limitations of current R2 and R2* based 
approaches. However, the model and algorithm have several limitations, including low 
SNR, physiologically impossible values, and impracticality resulted from the requirement 
of blood flow challenges. 
Chapter 5 and 6 attempted to address these limitations with some success. In chapter 
5, a new algorithm is proposed to denoise QSM based CMRO2 and OEF maps by 
incorporating prior knowledge (Bayesian approach) during image reconstruction. The prior 
knowledge include a right-handed preconditioner, a CMRO2 global constraint derived 
from straight sinus, and a physiological lower and upper bounds of 0 to 100 % on OEF 
maps. Caffeine administration is also replaced by hyperventilation as the vaso-restrictive 
challenge which reduced the protocol time by 4 folds. In chapter 6, a new algorithm named 
minimal local variance (MLV) is proposed to remove the requirement of vaso challenges 
in the QSM-based CMRO2 technique to further improve its clinical practicality. 
175 
 
One major limitation is the low SNR of CMRO2 and OEF maps. With current 
scanning parameters and reconstruction methods, CMRO2 map has a SNR of 5.78 ± 1.36, 
which is not ideal. To improve SNR there are several suggestions: 1) Use more advance 
hardware such as 7T scanner and 32 channel head coils; 2) More sophisticated algorithm 
with structural prior as constraints. 
Another limitation is that global OEFs were estimated from the straight sinus and 
global CBFs were estimated by taking the sum of all voxels in CBF maps covering the 
whole brain. However, straight sinus mainly drains medial brain tissues and deep gray 
matter, not cortical tissue / whole brain. Jugular vein or superior straight sinus (SSS) are 
more ideal places to measure both global OEF and global CBF as suggested by Wehrli (3). 
To obtain more accurate global CMRO2 measurement it is recommended to perform phase 
contrast scan on jugular vein or SSS.  
 Third limitation is that OEF was slightly lower (2.5%) in WM than in CGM in QSM 
based OEF maps. This observed discrepancy may be attributed to the lower CBF changes 
detected in WM than the changes in CGM after caffeine and HV challenges (-
6.0±4.3ml/100g/min vs -17.9±5.53ml/100g/min, p<0.01). The small absolute CBF change 
and the known challenges of accurately quantifying CBF in WM with ASL MRI perfusion 
make OEFs in these regions more difficult to resolve. Our protocol was based on a routine 
clinical protocol used at our institution. By modifying the protocol according to the recent 
white paper by Alsop et al (4), SNR could potentially be improved at a cost of scan time 
increase.  
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Forth limitation is the requirement of quantitative CBV measurements. For this 
feasibility study, CBV was estimated from CBF using an empirical relationship derived 
from normative PET data and the Grubb’s exponent of 0.38, which can be a source of error. 
This limitation may be addressed by direct measurements of CBV using technique such as 
dynamic study with contrast agent (5,6), or by non-contrast MRI with detailed vascular 
signal modeling such as Vascular Space Occupancy (VASO)(7-9),  fMRI with multiple 
inversion times (10), or quantitative BOLD (11,12). 
Fifth limitation is the lack of Hct measurements. We assumed Hct𝑠𝑠𝑠𝑠 = 0.47 and 
calculated Hct𝑡𝑡𝑡𝑡𝑠𝑠𝑠𝑠𝑡𝑡𝑡𝑡 as 0.759Hct𝑠𝑠𝑠𝑠 as measured in (13). In hyperventilation study, we have 
quantified the maximum CMRO2 estimation error caused by inter-subject variability of Hct𝑠𝑠𝑠𝑠 by repeating the calculations for both the lower (0.38) and upper bound (0.52) of the 
expected human Hctss range. For the cortical GM, the maximum difference between the 
CMRO2 value for Hct=0.47 and the two CMRO2 values obtained in this manner was 2.4 
± 1.1% (n=11). Hct can be measured through blood test with ease. Yet the ratio between Hct𝑠𝑠𝑠𝑠 and Hct𝑡𝑡𝑡𝑡𝑠𝑠𝑠𝑠𝑡𝑡𝑡𝑡 may vary spatially and among subjects. The potential error due to such 
variation warrants further investigation.  
There are several additional limitations in MLV approach. Firstly, the selection of 
block size requires further investigation. The MLV implemented in this study used an 
isotropic block size of 6x6x6mm3 such that multiple CBF voxels, acquired at a 3x3x3mm3 
isotropic resolution, were available within each block. This MLV implementation then 
resulted in multiple data points to uniquely estimate the two unknowns CMRO2 and 𝜒𝜒𝑛𝑛𝑛𝑛 
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within each block. This block size deemed to be large enough to avoid ill-posedness but 
not too large to avoid violating the homogeneous tissue assumptions. The optimal block 
size under different scanning resolutions and SNR need to be systematically studied.  
Secondly, in MLV χnb and CMRO2 are assumed to be constant within each block 
and each tissue type. Therefore, MLV derived CMRO2 values are block-wise constant and 
depend on accurate tissue segmentations. MLV may be further improved by considering 
physiologically relevant brain parcellations. In addition, robust tissue segmentation in 
patients need to be used to avoid violation of these assumptions. 
 
Thirdly, CMRO2 and OEF maps reconstructed using MLV are susceptible to piece-
wise appearance and partial volume effects. Averaging over several sub-block shifts, as 
done in this work, suppresses the resulting piecewise constant appearance. Highly 
deoxygenated vein contribution might be smoothed out with using block based method. If 
some voxels in the same tissue type have strong contribution from highly deoxygenated 
vein, it’s possible that this effect is smoothed out by the other voxels with low vein 
contribution. This limitation can be mitigated by acquiring higher resolution data and 
reduce block sizes. Trade off with SNR however needs to be considered. 
Lastly, clinical study and comparison against golden standard 15O positron emission 
tomography is warrant to study the effectiveness of the technique. 
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7.2 CONCLUSION 
In this dissertation, a clinical study on ICH using QSM was performed and a QSM/ 
ASL based technique was developed to quantitatively map CMRO2 and OEFs. The clinical 
study is the one of the first to quantitatively characterize hematoma susceptibilities at 
various stages using QSM.  QSM reveals positive susceptibility relative to CSF in 
hyperacute hematomas, indicating the existence of deoxyhemoglobin even in the 
hyperacute stage. QSM also reveals a significant reduction of susceptibility from acute to 
late subacute ICH, suggesting a decrease in methemoglobin concentration in the late 
subacute stage. Future studies are warrant to verify the finds with larger sample size and 
histological evidence. 
The developed QSM-based CMRO2 mapping technique overcome some of the 
fundamental limitations of R2 and R2* based MRI technique such as dependence on 
imaging parameters, and the requirement of blood flow challenges. Future studies are 
warrant to improve SNR, eliminate bias in WM in OEF maps, improve robustness, and 
validate against 15O PET in larger healthy and patient populations.  
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